Bot Detector
IJPC Seal
Download FREE Sample Issue or Article
LEARN MORE
Subscribe Today
A subscription to IJPC includes a print copy delivered by postal mail and on-line access to electronic PDF copies of your subscribed issues.
Author Search Results

Author Search Results for "Allen Loyd V Jr"
Title/Author
(Click for Abstract / Details / Purchase)
Issue/​Page
View/Buy
PreScription: Our Lives Are Shaped by the Decisions We Make!
Allen Loyd V Jr
Jul/Aug 2023
Pg. 268

Nonsterile Basics of Compounding: Compounding with Antioxidants, Part 1: An Overview
Allen Loyd V Jr
Jul/Aug 2023
Pg. 295-302

Sterile Basics of Compounding: Intravenous Admixture Compounding, Part 3: Preparation Procedures
Allen Loyd V Jr
Jul/Aug 2023
Pg. 305-313

Chlorhexidine and Cetrimide Lotion
Allen Loyd V Jr
Jul/Aug 2023
Pg. 316

Clobazam 5-mg/mL Suspension
Allen Loyd V Jr
Jul/Aug 2023
Pg. 317-318

Clotrimazole 1% and Betamethasone Dipropionate 0.05% Cream
Allen Loyd V Jr
Jul/Aug 2023
Pg. 319

Cyclosporine Topical Gel Formulation
Allen Loyd V Jr
Jul/Aug 2023
Pg. 320-321

Dexamethasone 1 mg/mL in Oral Mix SF
Allen Loyd V Jr
Jul/Aug 2023
Pg. 322

Lamotrigine 1 mg/mL in SuspendIt Plus
Allen Loyd V Jr
Jul/Aug 2023
Pg. 323

Levofloxacin 0.5% Topical Gel
Allen Loyd V Jr
Jul/Aug 2023
Pg. 324-325

Losartan Potassium 2.5-mg/mL Oral Liquid
Allen Loyd V Jr
Jul/Aug 2023
Pg. 326

Nystatin Oromucosal Gel
Allen Loyd V Jr
Jul/Aug 2023
Pg. 327

Rifampin 10-mg/mL Nasal Drops
Allen Loyd V Jr
Jul/Aug 2023
Pg. 328

Trihexyphenidyl Hydrochloride 1-mg/mL Oral Liquid, Alcohol-free
Allen Loyd V Jr
Jul/Aug 2023
Pg. 329

PreScription: Shortages Continue--Compounding Pharmacies Fill the Gap…Again!
Allen Loyd V Jr
May/Jun 2023
Pg. 180

Nonsterile Basics of Compounding: Compounding with Humectants
Allen Loyd V Jr
May/Jun 2023
Pg. 218-221

Sterile Basics: Intravenous Admixture Compounding, Part 2: Parenteral Vehicle Considerations
Allen Loyd V Jr
May/Jun 2023
Pg. 223-229

Acetaminophen 500-mg/mL Rectal Solution
Allen Loyd V Jr
May/Jun 2023
Pg. 232-233

Doxycycline 166.7-mg/mL Oral Suspension (Veterinary)
Allen Loyd V Jr
May/Jun 2023
Pg. 234

Gentamicin 480-mg/1000-mL Bladder Irrigation
Allen Loyd V Jr
May/Jun 2023
Pg. 235

Methylene Blue 5-mg Capsules
Allen Loyd V Jr
May/Jun 2023
Pg. 236

Migraine Headache Suppositories
Allen Loyd V Jr
May/Jun 2023
Pg. 237

Nifedipine, Lidocaine, and Nitroglycerin Suppositories
Allen Loyd V Jr
May/Jun 2023
Pg. 238

Nystatin Oromucosal Viscous Suspension
Allen Loyd V Jr
May/Jun 2023
Pg. 239

PreScription: Amoxicillin Shortage Continues: Compounding Pharmacies Filling the Gap!
Allen Loyd V Jr
Mar/Apr 2023
Pg. 92

Sterile Basics: Intravenous Admixture Compounding, Part 1: Introduction and Overview of the General Guidelines for an Intravenous Admixture Compounding Program, and Compounding Personnel Considerations
Allen Loyd V Jr
Mar/Apr 2023
Pg. 123-139

Aminohippurate Sodium 250 mg/mL Injection
Allen Loyd V Jr
Mar/Apr 2023
Pg. 142

Amphotericin B 0.1% Topical Microemulsion
Allen Loyd V Jr
Mar/Apr 2023
Pg. 143

Aphthous Ulcer Gel
Allen Loyd V Jr
Mar/Apr 2023
Pg. 144

Bethanechol 0.01% in Lanolin 10% and White Petrolatum 90%
Allen Loyd V Jr
Mar/Apr 2023
Pg. 145

Cyclosporine Topical Microemulsion
Allen Loyd V Jr
Mar/Apr 2023
Pg. 146

Hypochlorous Acid 0.01% Oral Rinse
Allen Loyd V Jr
Mar/Apr 2023
Pg. 147

Nystatin, Lidocaine, Hydrocortisone, and Chlorhexidine Oral Rinse
Allen Loyd V Jr
Mar/Apr 2023
Pg. 148

Pilocarpine Hydrochloride 0.3% w/v Solution
Allen Loyd V Jr
Mar/Apr 2023
Pg. 149-151

Sacrosidase 8,500 Units Per mL Oral Solution
Allen Loyd V Jr
Mar/Apr 2023
Pg. 152

Timolol 0.125%/Mucolox 15%/0.9% Normal Saline Nasal Spray
Allen Loyd V Jr
Mar/Apr 2023
Pg. 153

PreScription: New Drug Approvals 2022 and Compounding Opportunities
Allen Loyd V Jr
Jan/Feb 2023
Pg. 4

Advanced Compounding: Compounding with Microneedle Arrays, Part 3: Microneedle Array Development in the Literature and Quality Control of Microneedle Arrays
Allen Loyd V Jr
Jan/Feb 2023
Pg. 30-37

Acetaminophen 10 mg/mL for Rectal Use
Allen Loyd V Jr
Jan/Feb 2023
Pg. 50

Clozapine 20 mg/mL in Ora-Sweet and Ora-Plus
Allen Loyd V Jr
Jan/Feb 2023
Pg. 51

Dapsone 2 mg/mL in Ora-Sweet and Ora-Plus
Allen Loyd V Jr
Jan/Feb 2023
Pg. 52

Erlotinib 10 mg/mL in Ora-Sweet and Ora-Plus
Allen Loyd V Jr
Jan/Feb 2023
Pg. 53

Manning's Liniment
Allen Loyd V Jr
Jan/Feb 2023
Pg. 54

Mayer's Ointment
Allen Loyd V Jr
Jan/Feb 2023
Pg. 55

Povidone Iodine 100-mg/mL Solution/Spray
Allen Loyd V Jr
Jan/Feb 2023
Pg. 56

Psoriasis Topical Ointment
Allen Loyd V Jr
Jan/Feb 2023
Pg. 57

Suspension Solution, Sugar Free
Allen Loyd V Jr
Jan/Feb 2023
Pg. 58-59

PreScription: Compounded Drugs Often Become Manufactured Drugs
Allen Loyd V Jr
Nov/Dec 2022
Pg. 444

Compounding with Biotechnology Products, Part 2: Product-specific Considerations
Allen Loyd V Jr
Nov/Dec 2022
Pg. 446-466

Compounding with Microneedle Arrays, Part 2: Preparation and Administration Methods
Allen Loyd V Jr
Nov/Dec 2022
Pg. 490-495

Bacitracin 0.01% and Phenol 0.1% in Cetaphil Lotion
Allen Loyd V Jr
Nov/Dec 2022
Pg. 508

Curcumin 2% Topical Gel
Allen Loyd V Jr
Nov/Dec 2022
Pg. 509

Diazoxide 10-mg/mL in Oral Mix SF
Allen Loyd V Jr
Nov/Dec 2022
Pg. 510

Enrofloxacin 11.35 mg/mL in Ora-Blend, Veterinary
Allen Loyd V Jr
Nov/Dec 2022
Pg. 511

Flucytosine 50 mg/mL in Oral-Sweet and Ora-Plus
Allen Loyd V Jr
Nov/Dec 2022
Pg. 512

Granisetron Hydrochloride 005 mg/mL in Ora-Sweet and Ora-Plus
Allen Loyd V Jr
Nov/Dec 2022
Pg. 513

Miller's Modified Mouthwash
Allen Loyd V Jr
Nov/Dec 2022
Pg. 514

Potassium Alum 1% Bladder Irrigation for Hemorrhagic Cystitis (Low-Medium Risk Compounding)
Allen Loyd V Jr
Nov/Dec 2022
Pg. 515

PreScription: A New Dosage Form
Allen Loyd V Jr
Sep/Oct 2022
Pg. 356

Compounding with Biotechnology Products, Part 1: General Considerations
Allen Loyd V Jr
Sep/Oct 2022
Pg. 385-395

Basics of Compounding: Compounding with Microneedle Arrays, Part 1: Introduction and Overview
Allen Loyd V Jr
Sep/Oct 2022
Pg. 400-408

Amphotericin B 3% Otic Gel
Allen Loyd V Jr
Sep/Oct 2022
Pg. 422

Ascorbic acid 5% Topical Microemulsion
Allen Loyd V Jr
Sep/Oct 2022
Pg. 423

Chlorhexidine Diacetate 2% Topical Gel
Allen Loyd V Jr
Sep/Oct 2022
Pg. 424

Clindamycin Hydrochloride 10-mg/mL Oral Suspension
Allen Loyd V Jr
Sep/Oct 2022
Pg. 425

Clotrimazole 10-mg Troches
Allen Loyd V Jr
Sep/Oct 2022
Pg. 426

Cysteamine Hydrochloride 100 mg/mL Oral Solution
Allen Loyd V Jr
Sep/Oct 2022
Pg. 427

Hydrogen Peroxide 1.5% with Sodium Fluoride 0.5-mg/mL Oral Rinse
Allen Loyd V Jr
Sep/Oct 2022
Pg. 428

Lansoprazole 3-mg/mL in Ora-Blend Suspension
Allen Loyd V Jr
Sep/Oct 2022
Pg. 429

Metronidazole 10%, Nifedipine 0.5%, Lidocaine 1.5%, and Diclofenac 3% Ointment
Allen Loyd V Jr
Sep/Oct 2022
Pg. 430

Methylcobalamin 2-mg/mL Nasal Spray
Allen Loyd V Jr
Sep/Oct 2022
Pg. 431

PreScription: Pharmacy and Drug Information
Allen Loyd V Jr
Jul/Aug 2022
Pg. 268

Basics: Hollow-type Suppositories
Allen Loyd V Jr
Jul/Aug 2022
Pg. 302-307

Betamethasone Dipropionate 0.05% and Salicylic Acid 3% Lotion
Allen Loyd V Jr
Jul/Aug 2022
Pg. 318

Cetrimide Lotion
Allen Loyd V Jr
Jul/Aug 2022
Pg. 319

Dexamethasone 1 mg/mL in Oral Mix
Allen Loyd V Jr
Jul/Aug 2022
Pg. 320

Furosemide 5-mg/mL Oral Suspension
Allen Loyd V Jr
Jul/Aug 2022
Pg. 321-322

Hydralazine Hydrochloride 10 mg/mL Oral Liquid
Allen Loyd V Jr
Jul/Aug 2022
Pg. 323-324

Indomethacin 1% Topical Gel
Allen Loyd V Jr
Jul/Aug 2022
Pg. 325-326

Nystatin 250,000-unit Frozen Popsicles
Allen Loyd V Jr
Jul/Aug 2022
Pg. 327

Povidone Iodine 100-mg/mL Solution/Spray
Allen Loyd V Jr
Jul/Aug 2022
Pg. 328

Psoriasis Topical Ointment
Allen Loyd V Jr
Jul/Aug 2022
Pg. 329

PreScription: Standing in the Gap
Allen Loyd V Jr
May/Jun 2022
Pg. 180

Compounding for Investigational and Clinical Studies
Allen Loyd V Jr
May/Jun 2022
Pg. 201-209

Basics of Compounding: Vehicle for Drug Administration via Enteral Feeding Tubes
Allen Loyd V Jr
May/Jun 2022
Pg. 214-217

Sterile Basics of Compounding: Particulates in Parenteral Preparations: Sources, Minimization, and Detection
Allen Loyd V Jr
May/Jun 2022
Pg. 219-228

Alendronate Sodium 1% Topical Dental Gel
Allen Loyd V Jr
May/Jun 2022
Pg. 232

Azstarys in Ora-Blend Single Dose
Allen Loyd V Jr
May/Jun 2022
Pg. 233

Candesartan Cilexitil 1 mg/mL Syrup
Allen Loyd V Jr
May/Jun 2022
Pg. 234

Chloral Hydrate 70 mg/mL Syrup
Allen Loyd V Jr
May/Jun 2022
Pg. 235

Cinnarizine 1 mg/mL in Oral Medium-Chain Triglycerides Anhydrous Vehicle
Allen Loyd V Jr
May/Jun 2022
Pg. 236

Clobazam 1 mg/mL in Oral-Mix Suspension
Allen Loyd V Jr
May/Jun 2022
Pg. 237

Metronidazole 7.5 mg/mL Topical Oil-in-Water Microemulsion
Allen Loyd V Jr
May/Jun 2022
Pg. 238

Nitrazepam 1 mg/mL Oral Solution
Allen Loyd V Jr
May/Jun 2022
Pg. 239

Sirolimus 0.1% Ointment
Allen Loyd V Jr
May/Jun 2022
Pg. 240

Valganciclovir 20 mg/mL in Ora-Plus and Ora-Sweet Suspension
Allen Loyd V Jr
May/Jun 2022
Pg. 241

PreScription: Comments on the FDA Guidance "Compounded Drug Products That Are Essentially Copies of a Commercially Available Drug Product Under Section 503A of the Federal Food, Drug, and Cosmetic Act: Guidance for Industry"
Allen Loyd V Jr
Mar/Apr 2022
Pg. 92

Quality Control: Photodocumentation in Pharmacy Compounding
Allen Loyd V Jr
Mar/Apr 2022
Pg. 116-117

Basics of Compounding: Compounding Nonsterile Preparations Using Cyclodextrins
Allen Loyd V Jr
Mar/Apr 2022
Pg. 118-126

Sterile Basics of Compounding: Methods of Sterilization and Depyrogenation
Allen Loyd V Jr
Mar/Apr 2022
Pg. 129-136

Alprazolam 1 mg/mL in SyrSpend SF pH4 Oral Suspension
Allen Loyd V Jr
Mar/Apr 2022
Pg. 140

Codeine Phosphate 3 mg/mL in Ora-Sweet
Allen Loyd V Jr
Mar/Apr 2022
Pg. 141

Ketoconazole 2%, Terbenafine 1%, Acetic Acid 2%, and Urea 2% in Dimethyl Sulfoxide Nail Polish
Allen Loyd V Jr
Mar/Apr 2022
Pg. 142

Lorazepam 1 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
Mar/Apr 2022
Pg. 143

Mesalamine 100-mg/mL Suspension Enema
Allen Loyd V Jr
Mar/Apr 2022
Pg. 144

Naproxen 25 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
Mar/Apr 2022
Pg. 145

Phenobarbital 10 mg/mL in SyrSpend SF pH4, Cherry Flavored
Allen Loyd V Jr
Mar/Apr 2022
Pg. 146

Phenytoin 15 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
Mar/Apr 2022
Pg. 147

Propranolol 2 mg/mL and 5 mg/mL in Ora-Blend SF Suspension
Allen Loyd V Jr
Mar/Apr 2022
Pg. 148

Pyridoxine Hydrochloride 50 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
Mar/Apr 2022
Pg. 149

PreScription: IJPC--Starting Year 26
Allen Loyd V Jr
Jan/Feb 2022
Pg. 4

Editorial: Should All Pharmacists Compound?
Allen Loyd V Jr
Jan/Feb 2022
Pg. 24-28

Basics: Considerations and Background Information for Counseling Patients Using Compounded Suppositories
Allen Loyd V Jr
Jan/Feb 2022
Pg. 34-38

Sterile Basics: Compounding Sterile Preparations with Cyclodextrins
Allen Loyd V Jr
Jan/Feb 2022
Pg. 41-49

Aluminum Chloride 6.25% in Anhydrous Alcohol
Allen Loyd V Jr
Jan/Feb 2022
Pg. 52

Ascorbic Acid 10% in Anhydrous PEG ointment
Allen Loyd V Jr
Jan/Feb 2022
Pg. 53

Deoxyarbutin 3% Anhydrous Emulsion
Allen Loyd V Jr
Jan/Feb 2022
Pg. 54

Diclofenac Sodium 1%-15% Topical Gel
Allen Loyd V Jr
Jan/Feb 2022
Pg. 55

Enalapril Maleate 1 mg-mL in Ora-Plus and Ora-Sweet Suspension
Allen Loyd V Jr
Jan/Feb 2022
Pg. 56

Mometasone Furoate 0.1% Lotion
Allen Loyd V Jr
Jan/Feb 2022
Pg. 57

PreScription: IJPC -- Twenty-Five Year Anniversary
Allen Loyd V Jr
Nov/Dec 2021
Pg. 444

Basics of Compounding: Excipients Used in Nonsterile Compounding, Part 12: Sorbents (Adsorbents and Absorbents)
Allen Loyd V Jr
Nov/Dec 2021
Pg. 486-489

Basics of Sterile Compounding: Intravenous Admixture Preparation, Part 12: United States Pharmacopeia Chapters Referenced in the Current United States Pharmacopeia Chapter <797> Pharmaceutical Compounding -- Sterile Preparations
Allen Loyd V Jr
Nov/Dec 2021
Pg. 491-496

Domperidone 5 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
Nov/Dec 2021
Pg. 500

Kayexalate in Lactulose
Allen Loyd V Jr
Nov/Dec 2021
Pg. 501

Levetiracetam 50 mg/mL in Ora-Sweet and Ora-Plus Suspension
Allen Loyd V Jr
Nov/Dec 2021
Pg. 502

Metoprolol Tartrate 10 mg/mL in SyrSpend SF pH4 Oral Suspension
Allen Loyd V Jr
Nov/Dec 2021
Pg. 503

Propranolol 2 mg/mL or 5 mg/mL in Ora-Sweet
Allen Loyd V Jr
Nov/Dec 2021
Pg. 504

Pyridoxine Hydrochloride 25 mg/mL in Oral Mix and Oral Mix SF Suspension
Allen Loyd V Jr
Nov/Dec 2021
Pg. 505

Quetiapine Fumarate 10 mg/mL in Ora-Blend
Allen Loyd V Jr
Nov/Dec 2021
Pg. 506

Shari's Burn Cream
Allen Loyd V Jr
Nov/Dec 2021
Pg. 507

Sulfadiazine 100 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
Nov/Dec 2021
Pg. 508

Ziprasidone Mesylate 2.5 mg/mL in Ora-Sweet Suspension
Allen Loyd V Jr
Nov/Dec 2021
Pg. 509

PreScription: Permissible Exposure Limits and United States Pharmacopeia Chapter <800>
Allen Loyd V Jr
Sep/Oct 2021
Pg. 356

Basics of Compounding: Excipients Used in Nonsterile Compounding, Part 11: Drug Tastes: Innate, Induced, and Improved
Allen Loyd V Jr
Sep/Oct 2021
Pg. 396-400

Basics of Sterile Compounding: Intravenous Admixture Preparation, Part 11: Particulate Issues --- Silicone Oil in Vials, Cartridges, and Syringes
Allen Loyd V Jr
Sep/Oct 2021
Pg. 403-408

Atropine Sulfate 0.1 mg/mL in SyrSpend SF pH4 Oral Suspension
Allen Loyd V Jr
Sep/Oct 2021
Pg. 412

Cilazapril 1-mg/mL in Ora-Blend Suspension
Allen Loyd V Jr
Sep/Oct 2021
Pg. 413

Clonidine 0.01-mg/mL in Ora-Blend Suspension
Allen Loyd V Jr
Sep/Oct 2021
Pg. 414

Dapsone 2-mg/mL in Oral Mix or Oral Mix SF Suspension
Allen Loyd V Jr
Sep/Oct 2021
Pg. 415

Dexamethasone 1-mg/mL in Oral Mix or Oral Mix SF Suspension
Allen Loyd V Jr
Sep/Oct 2021
Pg. 416

Haloperidol 0.5-mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
Sep/Oct 2021
Pg. 417

Imipramine Hydrochloride 5-mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
Sep/Oct 2021
Pg. 418

Mycophenolate Mofetil 50-mg/mL in Ora-Plus:Cherry Syrup Suspension
Allen Loyd V Jr
Sep/Oct 2021
Pg. 419

Sorafenib 20-mg/mL in Oil Oral Suspension
Allen Loyd V Jr
Sep/Oct 2021
Pg. 420

Spironolactone 2-mg/mL or 2-5.mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
Sep/Oct 2021
Pg. 421

PreScription: Endemics, Epidemics, and Pandemics
Allen Loyd V Jr
Jul/Aug 2021
Pg. 268

Basics of Compounding: Excipients Used in Nonsterile Compounding, Part 10: Rectal Suppository Bases
Allen Loyd V Jr
Jul/Aug 2021
Pg. 304-309

Basics of Sterile Compounding: Intravenous Admixture Preparation Considerations, Part 10: Packaging and Container-closure Issues
Allen Loyd V Jr
Jul/Aug 2021
Pg. 311-317

Apixaban 0.25-mg/mL Suspension for Enteral Feeding Tube
Allen Loyd V Jr
Jul/Aug 2021
Pg. 320

Atomoxetine 4-mg/mL Oral Solution/Suspension
Allen Loyd V Jr
Jul/Aug 2021
Pg. 321

BHR in PLO Gel (Benadryl, Haldol, and Reglan in Pluronic Lecithin Organogel)
Allen Loyd V Jr
Jul/Aug 2021
Pg. 322

Budesonide 0.0.25% Mucoadhesive Gel
Allen Loyd V Jr
Jul/Aug 2021
Pg. 323

Cyclopentolate Hydrochloride 0.5%, Phenylephrine HCl 2.5%, and Tropicamide 0.5% Ophthalmic Solution
Allen Loyd V Jr
Jul/Aug 2021
Pg. 324

Hydrocortisone 2-mg/mL in Oral Mix Suspension
Allen Loyd V Jr
Jul/Aug 2021
Pg. 325

Moh's Paste, Modified
Allen Loyd V Jr
Jul/Aug 2021
Pg. 326

Nifedipine 4.mg/mL in SyrSpend SF pH4 Cherry Flavored
Allen Loyd V Jr
Jul/Aug 2021
Pg. 327

Tacrolimus 0.1% Topical Microemulsion
Allen Loyd V Jr
Jul/Aug 2021
Pg. 328

Valsartan 4-mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
Jul/Aug 2021
Pg. 329

PreScription: The Ethical Pharmacist
Allen Loyd V Jr
May/Jun 2021
Pg. 180

Basics of Compounding: Excipients Used in Nonsterile Compounding: Diluents
Allen Loyd V Jr
May/Jun 2021
Pg. 218-221

Intravenous Admixture Preparation Considerations, Part 9-B: Error Prevention in Intravenous Admixture Preparation
Allen Loyd V Jr
May/Jun 2021
Pg. 222-229

Levofloxacin 50-mg/mL in Ora-Plus and Strawberry Syrup Suspension
Allen Loyd V Jr
May/Jun 2021
Pg. 232

Naltrexone Hydrochloride 0.5 mg/mL and 5.0 mg/mL in SuspendIt Suspension
Allen Loyd V Jr
May/Jun 2021
Pg. 233

Tacrolimus 0.5 mg/mL in Ora-Plus and Simple Syrup Suspension
Allen Loyd V Jr
May/Jun 2021
Pg. 234

Temozolomide 10 mg/mL in Oral Mix SF Suspension
Allen Loyd V Jr
May/Jun 2021
Pg. 235

PreScription: The Past (-->2020), The Present, and The Future (2021-->)
Allen Loyd V Jr
Mar/Apr 2021
Pg. 92

Basics of Compounding: Excipients Used in Nonsterile Compounding, Part 8: Humectants
Allen Loyd V Jr
Mar/Apr 2021
Pg. 126-128

Intravenous Admixture Preparation Considerations, Part 9-A: Error Prevention in Intravenous Admixture Preparation
Allen Loyd V Jr
Mar/Apr 2021
Pg. 131-139

Amlodipine 1-mg/mL in Oral Mix Suspension
Allen Loyd V Jr
Mar/Apr 2021
Pg. 142

Canine Soft Chew Base (Veterinary)
Allen Loyd V Jr
Mar/Apr 2021
Pg. 143

Eslicarbazepine Acetate 40-mg/mL in Ora-Plus with Ora-Sweet or Ora-Sweet SF Suspension
Allen Loyd V Jr
Mar/Apr 2021
Pg. 144

Levodopa/Carbidopa 5.0/1.25 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
Mar/Apr 2021
Pg. 145

PreScription: The NASEM cBHT Report, Part 2
Allen Loyd V Jr
Jan/Feb 2021
Pg. 4

Intravenous Admixture Preparation Considerations, Part 8: Ready-to-Use Preparations
Allen Loyd V Jr
Jan/Feb 2021
Pg. 31-38

Acetaminophen (Paracetamol) 50 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
Jan/Feb 2021
Pg. 42

Amlodipine Besylate 0.5-mg/mL to 10-mg/mL in SuspendIt Oral Suspension
Allen Loyd V Jr
Jan/Feb 2021
Pg. 43

Clonidine 0.01-mg/mL in Oral Mix and Oral Mix SF Suspension
Allen Loyd V Jr
Jan/Feb 2021
Pg. 44

Cyclophosphamide 10 mg/mL in Oral-Plus or Simple Syrup Suspension
Allen Loyd V Jr
Jan/Feb 2021
Pg. 45

Diclofenac Sodium 5 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
Jan/Feb 2021
Pg. 46

Metronidazole 50-mg/mL in Oral Mix and Oral Mix SF Suspension
Allen Loyd V Jr
Jan/Feb 2021
Pg. 47

PreScription: The NASEM cBHT Report, Part 1
Allen Loyd V Jr
Nov/Dec 2020
Pg. 444

NASEM Report on Compounded Topical Pain Creams
Allen Loyd V Jr
Nov/Dec 2020
Pg. 446-448

Intravenous Admixture Preparation Considerations, Part 7: Stability Issues
Allen Loyd V Jr
Nov/Dec 2020
Pg. 473-478

Safety and Efficacy Studies, Pharmacy Education, and the NASEM Report on Compounded Topical Pain Creams
Allen Loyd V Jr
Sep/Oct 2020
Pg. 356

Basics of Compounding: Excipients Used in Nonsterile Compounding, Part 7: Compounding with Surfactants
Allen Loyd V Jr
Sep/Oct 2020
Pg. 388-395

Intravenous Admixture Preparation Considerations, Part 6: pH Considerations -- Applications
Allen Loyd V Jr
Sep/Oct 2020
Pg. 397-402

Ketamine 60.6-mg/mL, Acepromazine 0.6-mg/mL, and Xylazine 6.67-mg/mL Injection (Vet-Rat and Hamster); Ketamine 6.06-mg/mL, Acepromazine 0.06-mg/mL, and Xylazine 0.667-mg/mL Injection (Vet-Mouse)
Allen Loyd V Jr
Sep/Oct 2020
Pg. 406

Levofloxacin 50 mg/mL in SyrSpend SF pH4 Oral Suspension
Allen Loyd V Jr
Sep/Oct 2020
Pg. 407

PreScription: COVID-19 and Compounding Pharmacists
Allen Loyd V Jr
Jul/Aug 2020
Pg. 268

Sterile Basics: Intravenous Admixture Preparation Considerations, Part 5: pH Considerations
Allen Loyd V Jr
Jul/Aug 2020
Pg. 305-309

Benzonatate 50 mg/mL in Ora-Sweet
Allen Loyd V Jr
Jul/Aug 2020
Pg. 312

Cyclobenzaprine 5-mg/g and Guaifenesin 10-mg/g Transdermal Cream
Allen Loyd V Jr
Jul/Aug 2020
Pg. 313

Doxepin Hydrochloride 5% in Cetaphil Cream
Allen Loyd V Jr
Jul/Aug 2020
Pg. 314

Hydrocortisone Hemisuccinate 2 mg/mL or Hydrocortisone Sodium Phosphate 2 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
Jul/Aug 2020
Pg. 315

Hydroxychloroquine Sulfate 25 mg/mL in Ora-Plus:Ora-Sweet SF
Allen Loyd V Jr
Jul/Aug 2020
Pg. 316

Hydroxyzine (Pamoate) 25-mg/mL Oral Suspension
Allen Loyd V Jr
Jul/Aug 2020
Pg. 317

Lisinopril 1 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
Jul/Aug 2020
Pg. 318

Lorazepam 1 mg/mL in a Nonaqueous Cosolvent Vehicle
Allen Loyd V Jr
Jul/Aug 2020
Pg. 319

Sumatriptan, Lidocaine Hydrochloride, Dexamethasone, Pentoxifylline, and Ibuprofen Transdermal Cream (Migraine Cream)
Allen Loyd V Jr
Jul/Aug 2020
Pg. 320

Tramadol Hydrochloride 10 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
Jul/Aug 2020
Pg. 321

PreScription: Formal Appeals to United States Pharmacopeia Regarding USP Chapters <795>, <797>, and <825>: Part 2
Allen Loyd V Jr
May/Jun 2020
Pg. 180

Quality Control: Photostability of Compounded Preparations
Allen Loyd V Jr
May/Jun 2020
Pg. 200-205

Basics: Excipients Used in Nonsterile Compounding, Part 6: Compounding with Viscosity-increasing Agents
Allen Loyd V Jr
May/Jun 2020
Pg. 206-212

Sterile Basics: Intravenous Admixture Preparation Considerations, Part 4: Particulates
Allen Loyd V Jr
May/Jun 2020
Pg. 215-220

Baclofen 10 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
May/Jun 2020
Pg. 224

Dexamethasone 1 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
May/Jun 2020
Pg. 225

Diphenylcyclopropenone 0.1% or 3% in Isopropranol
Allen Loyd V Jr
May/Jun 2020
Pg. 226

Ibuprofen 400-mg and Cyclobenzaprine 2.5-mg Capsules
Allen Loyd V Jr
May/Jun 2020
Pg. 227

Monsel's Solution, Gel, and Paste
Allen Loyd V Jr
May/Jun 2020
Pg. 228

Prednisolone 1 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
May/Jun 2020
Pg. 229

Sildenafil 2.5 mg/mL in Methylcellulose 1%:Syrup (1:1) Oral Suspension
Allen Loyd V Jr
May/Jun 2020
Pg. 230

Tetracycline Hydrochloride 25 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
May/Jun 2020
Pg. 231

Ursodiol 100 mg/mL in Cod Liver Oil, Veterinary
Allen Loyd V Jr
May/Jun 2020
Pg. 232

Venlafaxine 15 mg/mL in Ora-Plus:Ora-Sweet (1:1) Suspension
Allen Loyd V Jr
May/Jun 2020
Pg. 233

PreScription: Formal Appeals to United States Pharmacopeia Regarding USP Chapters <795>,<797>, and <825>: Part 1
Allen Loyd V Jr
Mar/Apr 2020
Pg. 92

Basics of Nonsterile Compounding: Excipients Used in Nonsterile Compounding, Part 5: Compounding Using Solvents and Cosolvent Systems
Allen Loyd V Jr
Mar/Apr 2020
Pg. 114-118

Intravenous Admixture Preparation Considerations, Part 3: Methods and Techniques to Decrease Incompatibilities
Allen Loyd V Jr
Mar/Apr 2020
Pg. 121-126

Acetazolamide 25 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
Mar/Apr 2020
Pg. 130

Cholecalciferol 50,000 IU/mL in SyrSpend SF pH4
Allen Loyd V Jr
Mar/Apr 2020
Pg. 131

Glycopyrrolate 0.2 mg/mL in Ora-Plus:Ora-Sweet (1:1)
Allen Loyd V Jr
Mar/Apr 2020
Pg. 132

Minocycline Hydrochloride 10 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
Mar/Apr 2020
Pg. 133

Nitrofurantoin 2 mg/mL in SyrSpend SF pH4 Oral Suspension
Allen Loyd V Jr
Mar/Apr 2020
Pg. 134

Propylthiouracil 5 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
Mar/Apr 2020
Pg. 135

Quinidine Sulfate 10 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
Mar/Apr 2020
Pg. 136

Terbinafine 25 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
Mar/Apr 2020
Pg. 137

Topiramate 5 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
Mar/Apr 2020
Pg. 138

Valsartan 4 mg/mL in Syrup NF
Allen Loyd V Jr
Mar/Apr 2020
Pg. 139

PreScription: One Size Does Not Fit All!
Allen Loyd V Jr
Jan/Feb 2020
Pg. 4

Basics: Excipients Used in Nonsterile Compounding, Part 4: Antioxidants and Chelating Agents
Allen Loyd V Jr
Jan/Feb 2020
Pg. 38-43

Intravenous Admixture Preparation Considerations, Part 2: Incompatibilities and Factors Involved
Allen Loyd V Jr
Jan/Feb 2020
Pg. 44-50

Amiodarone Hydrochloride 5 mg/mL in SyrSpend SF pH4 Cherry Flavored
Allen Loyd V Jr
Jan/Feb 2020
Pg. 54

Glutamine 250 mg/mL in SyrSpend SF pH4 Oral Suspension
Allen Loyd V Jr
Jan/Feb 2020
Pg. 55

Glycopyrrolate 0.2 mg/mL in Methylcellulose 1% and Syrup
Allen Loyd V Jr
Jan/Feb 2020
Pg. 56

Hydrocortisone 2%, Iodoquinol 1% Metronidazole 10%, and Zinc Oxide 2% in Polyethylene Glycol Ointment
Allen Loyd V Jr
Jan/Feb 2020
Pg. 57

Isoniazid 10 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
Jan/Feb 2020
Pg. 58

LCD 5%, Salicylic Acid 6% in Clobetasol Propionate 0.05% Ointment
Allen Loyd V Jr
Jan/Feb 2020
Pg. 59

Ondansetron Hydrochloride 0.8 mg/mL in SyrSpend SF pH4 Oral Suspension
Allen Loyd V Jr
Jan/Feb 2020
Pg. 60

Potassium Chloride 1 mmol/mL in Ora-Sweet SF
Allen Loyd V Jr
Jan/Feb 2020
Pg. 61

Progesterone 100-mg, Melatonin 1-mg, and L-Theanine 200-mg Slow-Release Capsules
Allen Loyd V Jr
Jan/Feb 2020
Pg. 62

Venlafaxine 15 mg/mL in Syrup
Allen Loyd V Jr
Jan/Feb 2020
Pg. 63

PreScription: As Things Change….
Allen Loyd V Jr
Nov/Dec 2019
Pg. 444

Basics: Excipients Used in Nonsterile Compounding, Part 3: Preservatives
Allen Loyd V Jr
Nov/Dec 2019
Pg. 472-477

Intravenous Admixture Preparation Considerations, Part 1: Overview of Series on Personnel Selection for Intravenous Admixture Compounding
Allen Loyd V Jr
Nov/Dec 2019
Pg. 478-482

Gabapentin 50-mg/mL in SyrSpend SF Oral Suspension
Allen Loyd V Jr
Nov/Dec 2019
Pg. 486

Prednisolone Sodium Phosphate 1.4 mg/mL in SyrSpend SR pH4, Cherry Flavored
Allen Loyd V Jr
Nov/Dec 2019
Pg. 487

Pregabaline 20 mg/mL in SyrSpend SR pH4 Oral Suspension
Allen Loyd V Jr
Nov/Dec 2019
Pg. 488

Riboflavin 10 mg/mL in SyrSpend SF pH4 Oral Suspension
Allen Loyd V Jr
Nov/Dec 2019
Pg. 489

Sulfasalazine 100 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
Nov/Dec 2019
Pg. 490

Tacrolimus Monohydrate 1 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
Nov/Dec 2019
Pg. 491

Tadalafil 5 mg/mL in Oral-Plus:Ora-Sweet (1:1)
Allen Loyd V Jr
Nov/Dec 2019
Pg. 492

Ursodiol 30 mg/mL in SyrSpend SF Cherry Oral Suspension
Allen Loyd V Jr
Nov/Dec 2019
Pg. 493

Verapmail Hydrochloride 50 mg/mL in SyrSpend SF
Allen Loyd V Jr
Nov/Dec 2019
Pg. 494

Zonisamide 10 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
Nov/Dec 2019
Pg. 495

PreScription: Regulations, Laws, Standards, Guidelines, Procedures, Etc
Allen Loyd V Jr
Sep/Oct 2019
Pg. 356

Basics: Excipients Used in Nonsterile Compounding, Part 2
Allen Loyd V Jr
Sep/Oct 2019
Pg. 393-396

Sterile Basics: Pharmaceutical Waters Used in Sterile and Nonsterile Compounding
Allen Loyd V Jr
Sep/Oct 2019
Pg. 399-402

Allopurinol 20 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
Sep/Oct 2019
Pg. 406

Amitriptyline Hydrochloride 10 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
Sep/Oct 2019
Pg. 407

Dipyridamole 10 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
Sep/Oct 2019
Pg. 408

Omeprazole 2 mg/mL in SyrSpend SF Alka (Reconstituted)
Allen Loyd V Jr
Sep/Oct 2019
Pg. 409

Oxandrolone 3 mg/mL in SyrSpend SF pH4 Oral Suspension
Allen Loyd V Jr
Sep/Oct 2019
Pg. 410

Sorafenib Capsules for Pediatric Use
Allen Loyd V Jr
Sep/Oct 2019
Pg. 411

Valsartan 4 mg/mL in Vehicle for Oral Solution USP
Allen Loyd V Jr
Sep/Oct 2019
Pg. 412

Verapamil Hydrochloride 50 mg/mL in Ora-Plus:Ora-Sweet (1:1)
Allen Loyd V Jr
Sep/Oct 2019
Pg. 413

PreScription: Temperatures by Degrees
Allen Loyd V Jr
Jul/Aug 2019
Pg. 268

Summary of Quality-Control Testing for Sterile and Nonsterile Compounded Preparations, Part 2: Microbiological Testing
Allen Loyd V Jr
Jul/Aug 2019
Pg. 299-303

Basics: Excipients Used in Nonsterile Compounding, Part 1
Allen Loyd V Jr
Jul/Aug 2019
Pg. 305-311

Aripiprazole 1 mg/mL in Oral-Plus:Ora-Sweet (1:1) Oral Suspension
Allen Loyd V Jr
Jul/Aug 2019
Pg. 314

Candesartan Cilexetil 1 mg/mL in Syrup NF or Vehicle for Oral Solution USP
Allen Loyd V Jr
Jul/Aug 2019
Pg. 315

Domperidone 5 mg/mL in Oral Mix
Allen Loyd V Jr
Jul/Aug 2019
Pg. 316

Lorazepam 1 mg/mL in Anhydrous Organic Solvent System
Allen Loyd V Jr
Jul/Aug 2019
Pg. 317

Morphine Sulfate 0.2-mg/mL Solution Stored in Amber Oral Plastic Syringes
Allen Loyd V Jr
Jul/Aug 2019
Pg. 318

Rifampin 25 mg/mL in SyrSpend SF Oral Suspension
Allen Loyd V Jr
Jul/Aug 2019
Pg. 319

PreScription: Honesty/Ethics in Professions: The Gallup Polls
Allen Loyd V Jr
May/Jun 2019
Pg. 180

Summary of Quality-Control Testing for Sterile and Nonsterile Compounded Preparations, Part 1: Physical and Chemical Testing
Allen Loyd V Jr
May/Jun 2019
Pg. 211-216

Basics of Sterile Compounding: Vehicles Used in Sterile Compounding
Allen Loyd V Jr
May/Jun 2019
Pg. 221-228

Aripiprazole 1 mg/mL in Methylcellulose 1% Syrup Oral Suspension
Allen Loyd V Jr
May/Jun 2019
Pg. 230

Chloroquine Phosphate 15 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
May/Jun 2019
Pg. 231

Clopidogrel 5 mg/mL in a Sugar-Free Syrup
Allen Loyd V Jr
May/Jun 2019
Pg. 232

Flunisolide Nasal Spray
Allen Loyd V Jr
May/Jun 2019
Pg. 233

Mebeverine Hydrochloride 10 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
May/Jun 2019
Pg. 234

Methotrexate 2-mg/mL Oral Solution
Allen Loyd V Jr
May/Jun 2019
Pg. 235

Sildenafil 2.5 mg/mL in Ora-Plus:Ora-Sweet
Allen Loyd V Jr
May/Jun 2019
Pg. 236

Valsartan 16-mg/mL Oral Suspension
Allen Loyd V Jr
May/Jun 2019
Pg. 237

PreScription: Compounding with Cannabidiol
Allen Loyd V Jr
Mar/Apr 2019
Pg. 92

Basics of Compounding for Sterile, Nonsterile, and Quality Control Compounding: Process Analytical Technology: Appropriate for Sterile and Nonsterile Compounding?
Allen Loyd V Jr
Mar/Apr 2019
Pg. 123-130

Basics of Compounding: Summary of the Official United States Pharmacopeia Monographs for Compounded Preparations
Allen Loyd V Jr
Mar/Apr 2019
Pg. 135-143

Acetaminophen 50% Pluronic Lecithin Organogel Gel
Allen Loyd V Jr
Mar/Apr 2019
Pg. 146

Amlodipine 1 mg/mL in SyrSpend SF pH4 Oral Suspension
Allen Loyd V Jr
Mar/Apr 2019
Pg. 147

Captopril 0.8 mg/mL in SyrSpend SF Oral Suspension
Allen Loyd V Jr
Mar/Apr 2019
Pg. 148

Dexamethasone 2 mg/g Topical Paste, Veterinary
Allen Loyd V Jr
Mar/Apr 2019
Pg. 149

Ketoprofen 10% in Pluronic Lecithin Organogel
Allen Loyd V Jr
Mar/Apr 2019
Pg. 150

Perphenazine 0.5 mg/mL Oral Liquid
Allen Loyd V Jr
Mar/Apr 2019
Pg. 151

Rosuvastatin 20 mg/mL Oral Suspension
Allen Loyd V Jr
Mar/Apr 2019
Pg. 152

Tacrolimus 0.5 mg/mL in Oral Mix Suspension
Allen Loyd V Jr
Mar/Apr 2019
Pg. 153

PreScription: The Cost of Information
Allen Loyd V Jr
Jan/Feb 2019
Pg. 4

Basics of Compounding: Standardization of Compounded Medications
Allen Loyd V Jr
Jan/Feb 2019
Pg. 35-44

Ketoprofen 10% in Pluronic Lecithin Organogel
Allen Loyd V Jr
Jan/Feb 2019
Pg. 52

Ketoprofen 20-mg/mL in SyrSPend SF pH4 Oral Suspension
Allen Loyd V Jr
Jan/Feb 2019
Pg. 53

Lidocaine Hydrochloride, Diphenhydramine Hydrochloride, Aluminum Hydroxide–Magnesium Hydrochloride–Simethicone Mouthwashes
Allen Loyd V Jr
Jan/Feb 2019
Pg. 54

Magnesium Sulfate and Lidocaine Hydrochloride Injection in Prefilled Syringes
Allen Loyd V Jr
Jan/Feb 2019
Pg. 55

Methimazole 5 mg/0.1 mL in Pluronic Lecithin Organogel Gel, Veterinary
Allen Loyd V Jr
Jan/Feb 2019
Pg. 56

Minoxidil 1-mg/mL in Ora-Plus and Ora-Sweet SF Suspension
Allen Loyd V Jr
Jan/Feb 2019
Pg. 57

Omeprazole 1 mg/mL and 4 mg/mL in Humco Flavor Sweet Sugar-Free Oral Liquid
Allen Loyd V Jr
Jan/Feb 2019
Pg. 58

Orodispersible Film
Allen Loyd V Jr
Jan/Feb 2019
Pg. 59

Piperacillin 10 mg/mL in 0.9% Sodium Chloride Bladder Irrigation
Allen Loyd V Jr
Jan/Feb 2019
Pg. 60

Thiamine Hydrochloride 100 mg/mL in SurSPend SF pH4 Oral Suspension
Allen Loyd V Jr
Jan/Feb 2019
Pg. 61

PreScription: Standardized Concentrations: Pro or Con?
Allen Loyd V Jr
Nov/Dec 2018
Pg. 444

Clonazepam 0.2 mg/mL in SyrSpend SF pH4 Oral Suspension
Allen Loyd V Jr
Nov/Dec 2018
Pg. 492

Diltiazem Hydrochloride 12 mg/mL in SyrSpend SF pH4 Oral Suspension
Allen Loyd V Jr
Nov/Dec 2018
Pg. 493

Enalapril Maleate 1 mg/mL in SyrSpend SF pH4 Oral Suspension
Allen Loyd V Jr
Nov/Dec 2018
Pg. 494

Hydrocortisone 2 mg/mL in Inorpha Suspension
Allen Loyd V Jr
Nov/Dec 2018
Pg. 495

Hydroxyurea 100 mg/mL in Ora-Plus:Ora-Sweet, Ora-Plus: Ora-Sweet SF, Ora-Blend or Oral-Blend SF Oral Suspensions
Allen Loyd V Jr
Nov/Dec 2018
Pg. 496

Prednisone 5 mg/mL ir Oral Mix Suspension
Allen Loyd V Jr
Nov/Dec 2018
Pg. 497

Errata
Allen Loyd V Jr
Nov/Dec 2018
Pg. 527

PreScription: Updating Formulations
Allen Loyd V Jr
Sep/Oct 2018
Pg. 356

Cysteamine 0.5% Ophthalmic Solution
Allen Loyd V Jr
Sep/Oct 2018
Pg. 408

Fluoxetine 50 mg/mL in Pluronic Lecithin Organogel
Allen Loyd V Jr
Sep/Oct 2018
Pg. 409

Pergolide Mesylate 0.2-mg/mL Oral Liquid, Veterinary
Allen Loyd V Jr
Sep/Oct 2018
Pg. 410

Torsemide 5 mg/mL in Ora-Plus:Ora-Sweet Suspension
Allen Loyd V Jr
Sep/Oct 2018
Pg. 411

PreScription: Factors Related to Drug Waste and Pharmacy Solutions
Allen Loyd V Jr
Jul/Aug 2018
Pg. 268

Quality Control: Water Activity Considerations for Beyond-use Dates
Allen Loyd V Jr
Jul/Aug 2018
Pg. 288-293

Basics of Compounding--Nonsterile: Compounding Self-emulsifying Drug Delivery Systems and Other Self-emulsifying Lipid Formulations, Part 2
Allen Loyd V Jr
Jul/Aug 2018
Pg. 294-300

Anhydrous Medium-chain Triglycerides Gel
Allen Loyd V Jr
Jul/Aug 2018
Pg. 316

Budesonide 1-mg//10-mL Mucolox Oral Suspensions
Allen Loyd V Jr
Jul/Aug 2018
Pg. 317

Cinacalcet 5-mg/mL in Oral-Plus/Ora-Sweet Suspension
Allen Loyd V Jr
Jul/Aug 2018
Pg. 318

Ketoprofen 10% in Pluronic Lecithin Organogel
Allen Loyd V Jr
Jul/Aug 2018
Pg. 319

Metronidazole Benzoate 70 mg/mL in SyrSpend SF Oral Suspension
Allen Loyd V Jr
Jul/Aug 2018
Pg. 320

Midazolam 1 mg/mL in SyrSpend SF or SyrSpend SF Cherry
Allen Loyd V Jr
Jul/Aug 2018
Pg. 321

Minoxidil 50 mg/mL in Espumil Foam Base
Allen Loyd V Jr
Jul/Aug 2018
Pg. 322

Oseltamivir Phosphate 15 mg/mL in SyrSpend SF
Allen Loyd V Jr
Jul/Aug 2018
Pg. 323

Pentoxifylline 5% in Dermabase
Allen Loyd V Jr
Jul/Aug 2018
Pg. 324

Propranolol Hydrochloride 1 mg/mL in SyrSpend SF Oral Suspension
Allen Loyd V Jr
Jul/Aug 2018
Pg. 325

PreScription: Influence and Sphere of Influence
Allen Loyd V Jr
May/Jun 2018
Pg. 180

Quality Control–Sterile Compounding: Analytical Methods. Density Determinations and Quality Control in Nonsterile and Sterile Compounding
Allen Loyd V Jr
May/Jun 2018
Pg. 206-217

Basics of Compounding–Nonsterile: Compounding Self-emulsifying Drug Delivery Systems and Other Self-emulsifying Lipid Formulations, Part 1
Allen Loyd V Jr
May/Jun 2018
Pg. 220-228

Anhydrous Silicon Base Topical Gel Vehicle
Allen Loyd V Jr
May/Jun 2018
Pg. 232

Atenolol 1 mg/mL or 5 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
May/Jun 2018
Pg. 233

Dorzolamide 2% Ophthalmic Solution
Allen Loyd V Jr
May/Jun 2018
Pg. 234

Gabapentin 100 mg/mL in Oral Mix or Oral Mix SF Suspension
Allen Loyd V Jr
May/Jun 2018
Pg. 235

Pyrimethamine 2 mg/mL in Ora-Plus and Ora-Sweet Oral Suspension
Allen Loyd V Jr
May/Jun 2018
Pg. 236

Rolapitant Injectable Emulsion with Dexamethasone Sodium Phosphate Admixture
Allen Loyd V Jr
May/Jun 2018
Pg. 237

Simvastatin 1 mg/mL in SyrSpend SF pH4 Oral Suspension
Allen Loyd V Jr
May/Jun 2018
Pg. 238

Trimethoprim 20 mg/mL and Sulfadiazine 100 mg/mL in Suspendit Oral Suspension
Allen Loyd V Jr
May/Jun 2018
Pg. 239

PreScription: Drug Quality and Security Act Implementation Subcommittee Hearing
Allen Loyd V Jr
Mar/Apr 2018
Pg. 92

Pharmacogenomics: Precision Pharmacy in 503A Compounding
Drummond Joseph
, Bennet Daron, Allen Loyd V Jr
Mar/Apr 2018
Pg. 95-107

Basics of Compounding: Compounding Microemulsions
Allen Loyd V Jr
Mar/Apr 2018
Pg. 137-143

Clonidine Hydrochloride 10 mg/mL in Inorpha Solution
Allen Loyd V Jr
Mar/Apr 2018
Pg. 146

Dorzolamide 2% and Timolol 0.5% Ophthalmic Solution
Allen Loyd V Jr
Mar/Apr 2018
Pg. 147

Lamotrigine 1-mg/mL in SyrSpend SF pH4 Oral Suspension
Allen Loyd V Jr
Mar/Apr 2018
Pg. 148

Levodopa and Carbidopa Rectal Suspension
Allen Loyd V Jr
Mar/Apr 2018
Pg. 149

Prochlorperazine Edisylate 0.5% Nasal Spray
Allen Loyd V Jr
Mar/Apr 2018
Pg. 150

Rolapitant Injectable Emulsion with Palonosetron Hydrochloride Admixture
Allen Loyd V Jr
Mar/Apr 2018
Pg. 151

Spironolactone 5-mg/mL in Suspendit Oral Suspension
Allen Loyd V Jr
Mar/Apr 2018
Pg. 152

Trilostane 5-mg/mL in Cod Liver Oil Suspension (Vet)
Allen Loyd V Jr
Mar/Apr 2018
Pg. 153

PreScription: 2017--Some Good Things Happened and Some Others
Allen Loyd V Jr
Jan/Feb 2018
Pg. 4

Certification, Accreditation, and Credentialing for 503A Compounding Pharmacies
Pritchett Jon
, McCrory Gary, Kraemer Cheri, Jensen Brenda, Allen Loyd V Jr
Jan/Feb 2018
Pg. 7-16

Glutamate and Aspartate Cardioplegia Additive Solution
Allen Loyd V Jr
Jan/Feb 2018
Pg. 50

Mercaptopurine 50 mg/mL in Ora-Sweet and Ora-Plus Suspension
Allen Loyd V Jr
Jan/Feb 2018
Pg. 51

Metronidazole 50 mg/mL in Ora-Blend Suspension
Allen Loyd V Jr
Jan/Feb 2018
Pg. 52

Miconazole 10% in Recura Topical Cream
Allen Loyd V Jr
Jan/Feb 2018
Pg. 53

Naproxen 25 mg/mL in Oral Mix or Oral Mix SF
Allen Loyd V Jr
Jan/Feb 2018
Pg. 54

Penicillamine-D 50 mg/mL in SyrSpend SF pH4 Oral Suspension
Allen Loyd V Jr
Jan/Feb 2018
Pg. 55

Ranitidine 15 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
Jan/Feb 2018
Pg. 56

Sodium Citrate 9% Nasal Spray for Olfactory Disorders
Allen Loyd V Jr
Jan/Feb 2018
Pg. 57

Thalidomide 20 mg/mL in Ora-Plus and Ora-Sweet Suspension
Allen Loyd V Jr
Jan/Feb 2018
Pg. 58

Voriconazole 40-mg/mL Oral Suspension
Allen Loyd V Jr
Jan/Feb 2018
Pg. 59

PreScription: Issues with the NAMS 2017 Hormone Therapy Position Statement
Allen Loyd V Jr
Nov/Dec 2017
Pg. 444

Basics of Compounding: Compounding Irrigation Solutions for Sterile and Nonsterile Preparations
Allen Loyd V Jr
Nov/Dec 2017
Pg. 481-486

Amitriptyline 20 mg/mL in OraPlus:OraSweet Suspension
Allen Loyd V Jr
Nov/Dec 2017
Pg. 490

Dapsone 2 mg/mL in SyrSpend SF pH4 Oral Suspension
Allen Loyd V Jr
Nov/Dec 2017
Pg. 491

Fluconazole 10% in RECURA Cream
Allen Loyd V Jr
Nov/Dec 2017
Pg. 492

Haloperidol 5-mg/mL Injection
Allen Loyd V Jr
Nov/Dec 2017
Pg. 493

Hydroxychloroquine Sulfate 25 mg/mL in Oral Mix or Oral Mix SF
Allen Loyd V Jr
Nov/Dec 2017
Pg. 494

Promethazine Hydrochloride 12.5 mg/0.1 mL in PLO Gel
Allen Loyd V Jr
Nov/Dec 2017
Pg. 495

Spironolactone 5 mg/mL in SuspendIt Oral Suspension
Allen Loyd V Jr
Nov/Dec 2017
Pg. 496

Tolmetin 400-mg Capsules
Allen Loyd V Jr
Nov/Dec 2017
Pg. 497

Trace Elements Injection 5
Allen Loyd V Jr
Nov/Dec 2017
Pg. 498

Vancomycin 5-mg/mL Injection
Allen Loyd V Jr
Nov/Dec 2017
Pg. 499

PreScription: 2017 Pharmacy Compounding Issues: The U.S. Food and Drug Administration, Harzardous Drugs, and Wasted Drugs
Allen Loyd V Jr
Sep/Oct 2017
Pg. 356

Child-safety Containers/Devices and Compounding
Allen Loyd V Jr
Sep/Oct 2017
Pg. 364-370

Basics of Compounding: 3D Printing--Pharmacy Applications: Geometric Shape Effects on 3D Printing
Allen Loyd V Jr
Sep/Oct 2017
Pg. 388-392

Acetylcysteine Solutions for Inhalation
Allen Loyd V Jr
Sep/Oct 2017
Pg. 408

Carbamazepine 25-mg/mL in SyrSPend SF pH4 Oral Suspension
Allen Loyd V Jr
Sep/Oct 2017
Pg. 409

Etoposide 20-mg/mL Injection
Allen Loyd V Jr
Sep/Oct 2017
Pg. 410

Fentanyl Citrate 50-mcg/mL Injection
Allen Loyd V Jr
Sep/Oct 2017
Pg. 411

Fluoxymesterone 10-mg Capsules
Allen Loyd V Jr
Sep/Oct 2017
Pg. 412

Ioversol Injection
Allen Loyd V Jr
Sep/Oct 2017
Pg. 413

Levocarnitine 100-mg/mL Oral Solution
Allen Loyd V Jr
Sep/Oct 2017
Pg. 414

Peritoneal Dialysis Solution with 1.5%, 2.5%, or 4.25% Dextrose
Allen Loyd V Jr
Sep/Oct 2017
Pg. 415

Tacrolimus 0.3-mg/mL Ophthalmic Solution
Allen Loyd V Jr
Sep/Oct 2017
Pg. 416

Vancomycin 50 mg/mL in Oral Syrup Suspension
Allen Loyd V Jr
Sep/Oct 2017
Pg. 417

PreScription: Just Think About It!
Allen Loyd V Jr
Jul/Aug 2017
Pg. 268

Basics of Compounding: 3D Printing: Pharmacy Applications, Part 3: Compounding, Formulation Considerations, and the Future
Allen Loyd V Jr
Jul/Aug 2017
Pg. 293-298

Betamethasone 0.1% and Neomycin 0.6% Gel-Cream
Allen Loyd V Jr
Jul/Aug 2017
Pg. 312

Castor Oil 50% in Modified Pluronic Lecithin Organogel Gel
Allen Loyd V Jr
Jul/Aug 2017
Pg. 313

Copper Sulfate, Magnesium Sulfate, Phenylephrine, and Guaifenesin Pluronic Lecithin Organogel
Allen Loyd V Jr
Jul/Aug 2017
Pg. 314

Disopyramide 100-mg Capsules
Allen Loyd V Jr
Jul/Aug 2017
Pg. 315

Ferrous Sulfate 30-mg Fe/mL Oral Drops
Allen Loyd V Jr
Jul/Aug 2017
Pg. 316

Reteplase Injection
Allen Loyd V Jr
Jul/Aug 2017
Pg. 317

Sertraline Hydrochloride 10-mg/mL Oral Suspension
Allen Loyd V Jr
Jul/Aug 2017
Pg. 318

Tacrolimus 0.06% Ophthalmic Drops
Allen Loyd V Jr
Jul/Aug 2017
Pg. 319

Torsemide 10-mg/mL Injection
Allen Loyd V Jr
Jul/Aug 2017
Pg. 320

Tranilast 8% Pluronic Lecithin Organogel Gel
Allen Loyd V Jr
Jul/Aug 2017
Pg. 321

PreScription: United States Pharmacopeia Chapter <800> Comments and Alternatives
Allen Loyd V Jr
May/Jun 2017
Pg. 180

Basics of Compounding: 3D Printing--Pharmacy Applications, Part 2
Allen Loyd V Jr
May/Jun 2017
Pg. 215-220

Candesartan Cilexetil 0.1-mg/mL to 2.0-mg/mL Oral Suspension
Allen Loyd V Jr
May/Jun 2017
Pg. 232

Ketoconazole 20-mg/mL in SyrSpend SF pH4 Oral Suspension
Allen Loyd V Jr
May/Jun 2017
Pg. 233

Ketoprofen 10%, Baclofen 2%, Cyclobenzaprine Hydrochloride 2%, Lidocaine 2% in Lipopen Ultra Cream Base
Allen Loyd V Jr
May/Jun 2017
Pg. 234

Meloxicam 1% Topical Gel
Allen Loyd V Jr
May/Jun 2017
Pg. 235

Ofloxacin 0.3% Ophthalmic Solution
Allen Loyd V Jr
May/Jun 2017
Pg. 236

PVP Iodine 10% Antiseptic Cream
Allen Loyd V Jr
May/Jun 2017
Pg. 237

Tri-Est, Progesterone, and Testosterone in Versatile, Phytobase, Fitaline, and HRT Supreme Cream Bases
Allen Loyd V Jr
May/Jun 2017
Pg. 238

Trimethoprim 10-mg/mL Oral Suspension
Allen Loyd V Jr
May/Jun 2017
Pg. 239

PreScription: Whatever Happened to Common Sense?
Allen Loyd V Jr
Mar/Apr 2017
Pg. 92

Quality Control: (Material) Safety Data Sheets
Allen Loyd V Jr
Mar/Apr 2017
Pg. 118-124

Basics of Compounding: 3D Printing--Pharmacy Applications, Part 1
Allen Loyd V Jr
Mar/Apr 2017
Pg. 127-130

Azathioprine 10-mg/mL Oral Suspension
Allen Loyd V Jr
Mar/Apr 2017
Pg. 146

Candesartan Cilexetil 8 mg Liquid-Filled Capsules
Allen Loyd V Jr
Mar/Apr 2017
Pg. 147

Furosemide 10-mg/mL Oral Suspension
Allen Loyd V Jr
Mar/Apr 2017
Pg. 148

Ketoconazole 20-mg/mL Oral Suspension
Allen Loyd V Jr
Mar/Apr 2017
Pg. 149

PreScription: Compounding Pharmacy Issues for 2017
Allen Loyd V Jr
Jan/Feb 2017
Pg. 4

Analytic Methods Used in Quality Control in a Compounding Pharmacy
Allen Loyd V Jr
Jan/Feb 2017
Pg. 31-37

Basics of Compounding with Dilutions and Concentrates
Allen Loyd V Jr
Jan/Feb 2017
Pg. 39-45

Clindamycin 10-mg/mL Oral Suspension
Allen Loyd V Jr
Jan/Feb 2017
Pg. 60

Diazoxide 10-mg/mL Oral Suspension
Allen Loyd V Jr
Jan/Feb 2017
Pg. 61

Infliximab 1% Ophthalmic Solution
Allen Loyd V Jr
Jan/Feb 2017
Pg. 62

Nifedipine 0.5% Rectal Ointment
Allen Loyd V Jr
Jan/Feb 2017
Pg. 63

Tetracaine Hydrochloride 0.5% Ophthalmic Solution
Allen Loyd V Jr
Jan/Feb 2017
Pg. 64

Zonisamide 10-mg/mL Oral Suspension
Allen Loyd V Jr
Jan/Feb 2017
Pg. 65

PreScription: Two Decades of IJPC
Allen Loyd V Jr
Nov/Dec 2016
Pg. 444

Introduction to Quality Control in a Compounding Pharmacy
Allen Loyd V Jr
Nov/Dec 2016
Pg. 481-484

Basics of Compounding: Clinical Pharmaceutics, Part 2
Allen Loyd V Jr
Nov/Dec 2016
Pg. 485-493

Basics of Sterile Compounding: Ophthalmic Preparations, Part 2: Suspensions and Ointments
Allen Loyd V Jr
Nov/Dec 2016
Pg. 495-500

Alendronate 70-mg/75-mL Drinkable Formulation
Allen Loyd V Jr
Nov/Dec 2016
Pg. 504

Bosentan 6.25-mg/mL Oral Suspension
Allen Loyd V Jr
Nov/Dec 2016
Pg. 505

Capsaicin 0.025% and Doxepin 3.3% Cream
Allen Loyd V Jr
Nov/Dec 2016
Pg. 506

Enrofloxacin 0.5%, Ketoconazole 0.1%, and Triamcinolone Acetonide 0.1% Otic Gel
Allen Loyd V Jr
Nov/Dec 2016
Pg. 507

Erlotinib 10-mg/mL Oral Suspension
Allen Loyd V Jr
Nov/Dec 2016
Pg. 508

Flumazenil 0.1-mg/mL Injection
Allen Loyd V Jr
Nov/Dec 2016
Pg. 509

Imatinib 40-mg/mL Oral Suspension
Allen Loyd V Jr
Nov/Dec 2016
Pg. 510

Lapatinib Ditosylate 50-mg/mL Oral Suspension
Allen Loyd V Jr
Nov/Dec 2016
Pg. 511

Melatonin 2-mg/mL Oral Suspension
Allen Loyd V Jr
Nov/Dec 2016
Pg. 512

Menthol, Chloral Hydrate, and Camphor Analgesic Ointment
Allen Loyd V Jr
Nov/Dec 2016
Pg. 513

PreScription: Stability Studies and United States Pharmacopeia-National Formulary-Grade Chemicals
Allen Loyd V Jr
Sep/Oct 2016
Pg. 356

Basics of Compounding: Clinical Pharmaceutics, Part 1
Allen Loyd V Jr
Sep/Oct 2016
Pg. 389-396

Basics of Sterile Compounding: Ophthalmic Preparations, Part 1: Ophthalmic Solutions
Allen Loyd V Jr
Sep/Oct 2016
Pg. 399-404

Clobazam 1-mg/mL Oral Suspension
Allen Loyd V Jr
Sep/Oct 2016
Pg. 406

Estradiol 0.25 mg/g, Estrone 0.25 mg/g, and Estriol 2 mg/g in HRT Cream Base
Allen Loyd V Jr
Sep/Oct 2016
Pg. 407

Inamrinone 5-mg/mL Injection
Allen Loyd V Jr
Sep/Oct 2016
Pg. 408

Levetiracetam 50-mg/mL Oral Suspension
Allen Loyd V Jr
Sep/Oct 2016
Pg. 409

Naproxen 5% Cream
Allen Loyd V Jr
Sep/Oct 2016
Pg. 410

Permethrin 1% Lotion
Allen Loyd V Jr
Sep/Oct 2016
Pg. 411

Progesterone 10% Cream
Allen Loyd V Jr
Sep/Oct 2016
Pg. 412

Sodium Phosphate Oral Solution
Allen Loyd V Jr
Sep/Oct 2016
Pg. 413

Tetracaine Hydrochloride 2% Topical Solution
Allen Loyd V Jr
Sep/Oct 2016
Pg. 414

Tromethamine Injection
Allen Loyd V Jr
Sep/Oct 2016
Pg. 415

PreScription: Is the United States Pharmacopeial Convention, Inc., Authorized to Establish "Official" Practice Standards for Pharmacy, Medicine, and Nursing?
Allen Loyd V Jr
Jul/Aug 2016
Pg. 268

View Sample
Basics of Compounding: Compounding Films
Allen Loyd V Jr
Jul/Aug 2016
Pg. 298-305

Dolasetron Mesylate 20-mg/mL Injection
Allen Loyd V Jr
Jul/Aug 2016
Pg. 318

Gatifloxacin 0.5% Ophthalmic Solution
Allen Loyd V Jr
Jul/Aug 2016
Pg. 319

Mebendazole 100-mg Capsules
Allen Loyd V Jr
Jul/Aug 2016
Pg. 320

Neomycin Sulfate 25-mg/mL Oral Solution
Allen Loyd V Jr
Jul/Aug 2016
Pg. 321

Nystatin 100,000-units Vaginal Inserts
Allen Loyd V Jr
Jul/Aug 2016
Pg. 322

1,2-Octanediol 5% Topical Liquid
Allen Loyd V Jr
Jul/Aug 2016
Pg. 323

Phytonadione 1-mg/mL Oral Solution
Allen Loyd V Jr
Jul/Aug 2016
Pg. 324

Plasmingen and Hyaluronate Sodium Ophthalmic Solution
Allen Loyd V Jr
Jul/Aug 2016
Pg. 325

Scopolamine Hydrobromide 0.25% Ophthalmic Solution
Allen Loyd V Jr
Jul/Aug 2016
Pg. 326

Tretinoin 10-mg Oral Capsules
Allen Loyd V Jr
Jul/Aug 2016
Pg. 327

Discrepancies in the Law and the U.S. Food and Drug Administration Pharmacy Compounding Compliance Policy Guidelines
Allen Loyd V Jr
Jul/Aug 2016
Pg. 351

View Sample
PreScription: Patient Access to Pharmaceuticals
Allen Loyd V Jr
May/Jun 2016
Pg. 180

Basics of Compounding: Special Capsules
Allen Loyd V Jr
May/Jun 2016
Pg. 209-214

Carboplatin 50-mg/mL Injection
Allen Loyd V Jr
May/Jun 2016
Pg. 226

Cefotetan Disodium Injection
Allen Loyd V Jr
May/Jun 2016
Pg. 227

Dexamethasone 0.1%, Neomycin 0.35%, and Polymixin 10,000 Units/g Ophthalmic Ointment
Allen Loyd V Jr
May/Jun 2016
Pg. 228

Dexpanthenol 5% Nasal Spray
Allen Loyd V Jr
May/Jun 2016
Pg. 229

Indomethacin Gel
Allen Loyd V Jr
May/Jun 2016
Pg. 230

Ketamine Hydrochloride 5%, Gabapentin 10%, Clonidine Hydrochloride 0.2%, and Baclofen 2% in Lipoderm
Allen Loyd V Jr
May/Jun 2016
Pg. 231

Montelukast Sodium 5-mg Fast-Dissolving Film
Allen Loyd V Jr
May/Jun 2016
Pg. 232

Pain-Away II Headache Capsules
Allen Loyd V Jr
May/Jun 2016
Pg. 233

Sodium Nitroprusside 25-mg/mL Injection
Allen Loyd V Jr
May/Jun 2016
Pg. 234

Zolpidem Tartrate 5-mg and 10-mg Capsules
Allen Loyd V Jr
May/Jun 2016
Pg. 235

PreScription: Compounding: A Changing Paradigm
Allen Loyd V Jr
Mar/Apr 2016
Pg. 92

Basics of Compounding: Capsules
Allen Loyd V Jr
Mar/Apr 2016
Pg. 125-134

Blue Goo Anti-Itch Gel
Allen Loyd V Jr
Mar/Apr 2016
Pg. 144

Carvedilol 3.125-mg, 6.25-mg, 12.5 mg, or 25-mg capsules
Allen Loyd V Jr
Mar/Apr 2016
Pg. 145

Medicated Polyox Bandage for Skin Ulcers
Allen Loyd V Jr
Mar/Apr 2016
Pg. 146

Sumatriptan 5-mg or 20-mg per 100-μL Nasal Spray
Allen Loyd V Jr
Mar/Apr 2016
Pg. 147

PreScription: Starting Year 20!
Allen Loyd V Jr
Jan/Feb 2016
Pg. 4

Aprepitant 80-mg Capsules
Allen Loyd V Jr
Jan/Feb 2016
Pg. 48

Aripiprazole 10-mg Oral Dissolving Tablets
Allen Loyd V Jr
Jan/Feb 2016
Pg. 49

Benzocaine 20%, Lidocaine 6%, and Tetracaine 4% in Lipoderm
Allen Loyd V Jr
Jan/Feb 2016
Pg. 50

Dexamethasone, Neomycin, and Polymyxin Ophthalmic Ointment
Allen Loyd V Jr
Jan/Feb 2016
Pg. 51

Mupirocin Calcium 2% Cream
Allen Loyd V Jr
Jan/Feb 2016
Pg. 52

Resveratrol, Tocopherol Acetate, and Niacinamide Topical Gel-Cream
Allen Loyd V Jr
Jan/Feb 2016
Pg. 53

Thrombin 1,000 Units/mL Topical Solution, Sterile
Allen Loyd V Jr
Jan/Feb 2016
Pg. 54

Tropicamide 1% Ophthalmic Solution
Allen Loyd V Jr
Jan/Feb 2016
Pg. 55

Vancomycin 5% and Amikacin 2% Ophthalmic Solution
Allen Loyd V Jr
Jan/Feb 2016
Pg. 56

Voriconazole 10-mg/mL Ophthalmic Solution
Allen Loyd V Jr
Jan/Feb 2016
Pg. 57

PreScription: The Documented Past and the Exciting Future
Allen Loyd V Jr
Nov/Dec 2015
Pg. 442

U.S. Food and Drug Administration "Evaluation Criteria" for Difficult to Compound Drugs
Allen Loyd V Jr
Nov/Dec 2015
Pg. 487-488

Acetominophen and Codeine Phosphate (300-mg/30-mg) Capsules
Allen Loyd V Jr
Nov/Dec 2015
Pg. 504

Cefepime Hydrochloride 100-mg/mL Injection
Allen Loyd V Jr
Nov/Dec 2015
Pg. 505

Cefotaxime 100-mg/mL Injection
Allen Loyd V Jr
Nov/Dec 2015
Pg. 506

Chlorpromazine Hydrochloride 25-mg/mL Injection, Preserved
Allen Loyd V Jr
Nov/Dec 2015
Pg. 507

Dexamethasone Sodium Phosphate Ophthalmic Solution: Equivalent to 0.1% Dexamethasone Phosphate
Allen Loyd V Jr
Nov/Dec 2015
Pg. 508

Estradiol Valerate 40-mg/mL in Oil Injection
Allen Loyd V Jr
Nov/Dec 2015
Pg. 509

Levetiracetam 100-mg/mL Injection (Concentrate)
Allen Loyd V Jr
Nov/Dec 2015
Pg. 510

Memantine Hydrochloride Capsules
Allen Loyd V Jr
Nov/Dec 2015
Pg. 511

Mupirocin 2% Nasal Ointment
Allen Loyd V Jr
Nov/Dec 2015
Pg. 512

Propranolol Hydrochloride Capsules
Allen Loyd V Jr
Nov/Dec 2015
Pg. 513

PreScription: Failure or Success?
Allen Loyd V Jr
Sep/Oct 2015
Pg. 354

Nominations of Difficult to Compound Drugs to the U.S. Food and Drug Administration--Pharmacy Compounding Advisory Committee: Part 1
Allen Loyd V Jr
Sep/Oct 2015
Pg. 389-390

Aminocaproic Acid 250-mg/mL Oral Solution
Allen Loyd V Jr
Sep/Oct 2015
Pg. 404

Betamethasone Valerate 0.12%, Tranilast 1% Topical Gel
Allen Loyd V Jr
Sep/Oct 2015
Pg. 405

Lidocaine 2%, Metronidazole 2%, Misoprostol 0.0024% Topical Ointment
Allen Loyd V Jr
Sep/Oct 2015
Pg. 406

Nimodipine 3-mg/mL Oral Solution
Allen Loyd V Jr
Sep/Oct 2015
Pg. 407

Ofloxacin 0.3% Otic Solution
Allen Loyd V Jr
Sep/Oct 2015
Pg. 408

Povidone Iodine 10% Cold Sore Paint
Allen Loyd V Jr
Sep/Oct 2015
Pg. 409

Trichloroacetic Acid 20%, Salicylic Acid 20%, Lactic Acid 10% in Flexible Collodion
Allen Loyd V Jr
Sep/Oct 2015
Pg. 410

Vehicle for Oral Solution (National Formulary 26)
Allen Loyd V Jr
Sep/Oct 2015
Pg. 411

Vehicle for Oral Solution, Sugar Free (National Formulary 26)
Allen Loyd V Jr
Sep/Oct 2015
Pg. 412

Vehicle for Oral Suspension (National Formulary 26)
Allen Loyd V Jr
Sep/Oct 2015
Pg. 413

PreScription: 2015 Student Pharmacist Compounding Competition
Allen Loyd V Jr
May/Jun 2015
Pg. 180

Basics of Compounding: Compounding with Silicones
Allen Loyd V Jr
May/Jun 2015
Pg. 223-230

Atropine Sulfate 1% Ophthalmic Solution
Allen Loyd V Jr
May/Jun 2015
Pg. 242

Lidocaine Hydrochloride 2% Viscous Oral Topical Solution
Allen Loyd V Jr
May/Jun 2015
Pg. 243

Methylphenidate Hydrochloride 2.5-mg, 5-mg, or 10-mg Chewable Troches
Allen Loyd V Jr
May/Jun 2015
Pg. 244

Phenazopyridine Hydrochloride 200-mg Capsules
Allen Loyd V Jr
May/Jun 2015
Pg. 245

Physostigmine Salicylate 1-mg/mL Injection
Allen Loyd V Jr
May/Jun 2015
Pg. 246

Scopolamine Hydrobromide -.4-mg/mL Injection
Allen Loyd V Jr
May/Jun 2015
Pg. 247

PreScription: Some of the Best Sermons are Lived, not Preached!
Allen Loyd V Jr
Mar/Apr 2015
Pg. 92

Acne Scrub
Allen Loyd V Jr
Mar/Apr 2015
Pg. 142

Aminohippurate Sodium 200-mg/mL Injection
Allen Loyd V Jr
Mar/Apr 2015
Pg. 143

Deferoxamine Mesylate 213/mg/mL or 95-mg/mL Injection
Allen Loyd V Jr
Mar/Apr 2015
Pg. 144

Heparin 335-United/Gram Gel-Cream
Allen Loyd V Jr
Mar/Apr 2015
Pg. 145

L-Cysteine Hydrochloride 50-mg/mL Injection
Allen Loyd V Jr
Mar/Apr 2015
Pg. 146

Morrhuate Sodium 5% Injection
Allen Loyd V Jr
Mar/Apr 2015
Pg. 147

Oxycodone Hydrochloride 5-mg and Acetaminophen 325-mg per 5-mL Oral Solution
Allen Loyd V Jr
Mar/Apr 2015
Pg. 148

Pancuronium Bromide 1-mg/mL Injection
Allen Loyd V Jr
Mar/Apr 2015
Pg. 149

Physostigmine Salicylate 1-mg/mL Injection
Allen Loyd V Jr
Mar/Apr 2015
Pg. 150

Trypan Blue 0.06% Ophthalmic Solution
Allen Loyd V Jr
Mar/Apr 2015
Pg. 151

PreScription: 2014 in Review
Allen Loyd V Jr
Jan/Feb 2015
Pg. 4

Biotechnology, Nanotechnology, and Pharmacogenomics and Pharmaceutical Compounding, Part 1
Allen Loyd V Jr
Jan/Feb 2015
Pg. 38-40

Quality Control Analytical Methods: Refractive Index
Allen Loyd V Jr
Jan/Feb 2015
Pg. 43-47

Basics of Compounding: The Revised "Not to Compound List"
Allen Loyd V Jr
Jan/Feb 2015
Pg. 57-58

Atenolol 25-, 50-, or 100-mg Capsules
Allen Loyd V Jr
Jan/Feb 2015
Pg. 60

Azathioprine 50-mg Capsules
Allen Loyd V Jr
Jan/Feb 2015
Pg. 61

Cisplatin 1-mg/mL Injection
Allen Loyd V Jr
Jan/Feb 2015
Pg. 62

Daunorubicin 5-mg/mL Injection
Allen Loyd V Jr
Jan/Feb 2015
Pg. 63

Erythromycin 50-mg/mL Injection
Allen Loyd V Jr
Jan/Feb 2015
Pg. 64

Hydralazine Hydrochloride 20-mg/mL Injection
Allen Loyd V Jr
Jan/Feb 2015
Pg. 65

Hydroxychloroquine Sulfate 200-mg Capsules
Allen Loyd V Jr
Jan/Feb 2015
Pg. 66

Lidocaine Hydrochloride 4% Topical Solution
Allen Loyd V Jr
Jan/Feb 2015
Pg. 67

Mupirocin 2% Ointment
Allen Loyd V Jr
Jan/Feb 2015
Pg. 68

Phentolamine Mesylate 5-mg/mL Injection
Allen Loyd V Jr
Jan/Feb 2015
Pg. 69

PreScription: "Named Formulas" Database Available
Allen Loyd V Jr
Nov/Dec 2014
Pg. 444

Basics of Compounding: Tips and Hints, Part 6: Prescription Evaluation, Calculations, Ingredients, Quality-Assurance Practices, Patient Counseling, Shipping and Distribution, Miscellaneous
Allen Loyd V Jr
Nov/Dec 2014
Pg. 486-488

Clarithromycin 250-mg or 500-mg Capsules
Allen Loyd V Jr
Nov/Dec 2014
Pg. 494

Dexmedetomidine 100 mcg/mL Injection
Allen Loyd V Jr
Nov/Dec 2014
Pg. 495

Dexmethylphenidate Hydrochloride 2.5-mg, 5-mg, or 10-mg Capsules
Allen Loyd V Jr
Nov/Dec 2014
Pg. 496

Leucovorin 10-mg/mL Injection
Allen Loyd V Jr
Nov/Dec 2014
Pg. 497

Levocarnitine 200-mg/mL Injection
Allen Loyd V Jr
Nov/Dec 2014
Pg. 498

Methazolamide 25-mg or 50-mg Capsules
Allen Loyd V Jr
Nov/Dec 2014
Pg. 499

Methylene Blue 10-mg/mL Injection
Allen Loyd V Jr
Nov/Dec 2014
Pg. 500

Methylphenidate Hydrochloride 10-mg Capsules
Allen Loyd V Jr
Nov/Dec 2014
Pg. 501

Oxacillin Sodium 167-mg/mL Injection
Allen Loyd V Jr
Nov/Dec 2014
Pg. 502

Tamsulosin Hydrochloride 0.2-mg Capsules
Allen Loyd V Jr
Nov/Dec 2014
Pg. 503

PreScription: What is a Compounding Pharmacist?
Allen Loyd V Jr
Sep/Oct 2014
Pg. 356

Basics of Compounding: Tips and Hints, Part 5: Facilities and Equipment
Allen Loyd V Jr
Sep/Oct 2014
Pg. 401-404

Azithromycin 100-mg/mL Injection
Allen Loyd V Jr
Sep/Oct 2014
Pg. 408

Bacitracin Topical Ointment
Allen Loyd V Jr
Sep/Oct 2014
Pg. 409

Dexpanthenol 250-mg/mL Injection
Allen Loyd V Jr
Sep/Oct 2014
Pg. 410

Ephedrine Sulfate 50-mg/mL Injection
Allen Loyd V Jr
Sep/Oct 2014
Pg. 411

Fluorescein 100-mg/mL Injection
Allen Loyd V Jr
Sep/Oct 2014
Pg. 412

Indocyanine green 2.5-mg/mL Injection
Allen Loyd V Jr
Sep/Oct 2014
Pg. 413

Phenylephrine Hydrochloride 2.5%-Ophthalmic Solution
Allen Loyd V Jr
Sep/Oct 2014
Pg. 414

Sulfamethoxazole and Trimethoprim Oral Solution
Allen Loyd V Jr
Sep/Oct 2014
Pg. 415

Sumatriptan Succinate 12-mg/mL Injection
Allen Loyd V Jr
Sep/Oct 2014
Pg. 416

Tranexamic Acid 100-mg/mL Injection
Allen Loyd V Jr
Sep/Oct 2014
Pg. 417

PreScription: Challenging Times
Allen Loyd V Jr
Jul/Aug 2014
Pg. 268

Basics of Compounding Sterile Preparations: Nomenclature and Considerations
Allen Loyd V Jr
Jul/Aug 2014
Pg. 313-317

Basics of Compounding: Tips and Hints, Part 4: Lollipops/Lozenges, Gummy Bears, Patches, Flavoring/Coloring, Sweeteners, and Packaging
Allen Loyd V Jr
Jul/Aug 2014
Pg. 318-319

Atracurium Besylate 10-mg/mL Injection, Preserved
Allen Loyd V Jr
Jul/Aug 2014
Pg. 322

Barium Sulfate Suspension
Allen Loyd V Jr
Jul/Aug 2014
Pg. 323

Calcitriol 1-mcg/mL Injection
Allen Loyd V Jr
Jul/Aug 2014
Pg. 324

Chloramphenicol 100-mg/mL Injection
Allen Loyd V Jr
Jul/Aug 2014
Pg. 325

Chlorothiazide 50-mg/mL Oral Suspension
Allen Loyd V Jr
Jul/Aug 2014
Pg. 326

Choline Magnesium Trisalicylate Liquid
Allen Loyd V Jr
Jul/Aug 2014
Pg. 327

Denileukin Diftitox 150-mcg/mL Injection
Allen Loyd V Jr
Jul/Aug 2014
Pg. 328

Indigo Carmine Injection
Allen Loyd V Jr
Jul/Aug 2014
Pg. 329

Propranolol Hydrochloride 1-mg/mL Injection
Allen Loyd V Jr
Jul/Aug 2014
Pg. 330

Zinc 1-mg/mL Injection
Allen Loyd V Jr
Jul/Aug 2014
Pg. 331

PostScription: Responsibilities of a Compounding Pharmacist
Allen Loyd V Jr
Jul/Aug 2014
Pg. 351

PreScription: Déjà Vu All Over Again
Allen Loyd V Jr
May/Jun 2014
Pg. 180

Basics of Compounding: Tips and Hints, Part 3: Compounding with Ointments, Creams, Pastes, Gels, and Gel-creams
Allen Loyd V Jr
May/Jun 2014
Pg. 228-230

Atorvastatin 10-mg or 20-mg Capsules
Allen Loyd V Jr
May/Jun 2014
Pg. 232

Bumetanide 0.5-mg, 1-mg, or 2-mg Capsules
Allen Loyd V Jr
May/Jun 2014
Pg. 233

Bupivacaine Hydrochloride 0.5% Injection
Allen Loyd V Jr
May/Jun 2014
Pg. 234

Butorphanol Tartrate 10-mg/mL Nasal Spray
Allen Loyd V Jr
May/Jun 2014
Pg. 235

Dibucaine 1% Ointment
Allen Loyd V Jr
May/Jun 2014
Pg. 236

Lidocaine Hydrochloride 1% Injection
Allen Loyd V Jr
May/Jun 2014
Pg. 237

Methotrexate 2.5-mg Capsules
Allen Loyd V Jr
May/Jun 2014
Pg. 238

Naproxen 25-mg/mL Oral Suspension
Allen Loyd V Jr
May/Jun 2014
Pg. 239

Tamoxifen 10-mg or 20-mg Capsules
Allen Loyd V Jr
May/Jun 2014
Pg. 240

Thiothixene 1-mg, 2-mg, 5-mg, or 10-mg Capsules
Allen Loyd V Jr
May/Jun 2014
Pg. 241

PreScription: Standards vs Opinions
Allen Loyd V Jr
Mar/Apr 2014
Pg. 92

Basics of Sterile Compounding: Compounding by Weight Versus Compounding by Volume
Allen Loyd V Jr
Mar/Apr 2014
Pg. 131-134

Basics of Compounding: Tips and Hints, Part 2: Compounding with Solutions, Suspensions, Emulsions, and Lotions
Allen Loyd V Jr
Mar/Apr 2014
Pg. 137-138

Doxazosin 1-mg, 2-mg, 4-mg, or 8-mg Capsules
Allen Loyd V Jr
Mar/Apr 2014
Pg. 142

Fludarabine Phosphate 25-mg/mL Injection
Allen Loyd V Jr
Mar/Apr 2014
Pg. 143

Mecasermin 10-mg/mL Injection
Allen Loyd V Jr
Mar/Apr 2014
Pg. 144

Methylprednisolone 40-mg/mL Injection
Allen Loyd V Jr
Mar/Apr 2014
Pg. 145

Polymixin B Injection
Allen Loyd V Jr
Mar/Apr 2014
Pg. 146

Rocuronium Bromide 10-mg/mL Injection
Allen Loyd V Jr
Mar/Apr 2014
Pg. 147

Secretin 4 mcg/mL Injection
Allen Loyd V Jr
Mar/Apr 2014
Pg. 148

Selenium 40-mcg/mL Injection
Allen Loyd V Jr
Mar/Apr 2014
Pg. 149

Sincalide 1-mcg/mL Injection
Allen Loyd V Jr
Mar/Apr 2014
Pg. 150

Testosterone Enanthate 200-mg/mL Injection
Allen Loyd V Jr
Mar/Apr 2014
Pg. 151

PreScription: The International Journal of Pharmaceutical Compounding Begins Its 18th Year
Allen Loyd V Jr
Jan/Feb 2014
Pg. 4

Tips and Hints: Powders, Capsules, Tablets, Suppositories, and Sticks
Allen Loyd V Jr
Jan/Feb 2014
Pg. 42-45

Aztreonam Injection
Allen Loyd V Jr
Jan/Feb 2014
Pg. 60

Bumetanide 0.25-mg/mL Injection
Allen Loyd V Jr
Jan/Feb 2014
Pg. 61

Droperidol 2.5-mg/mL Injection
Allen Loyd V Jr
Jan/Feb 2014
Pg. 62

Lomustine 100-mg Capsules
Allen Loyd V Jr
Jan/Feb 2014
Pg. 63

Neostigmine Bromide 15-mg Capsules
Allen Loyd V Jr
Jan/Feb 2014
Pg. 64

Nimodipine 30-mg Capsules
Allen Loyd V Jr
Jan/Feb 2014
Pg. 65

Phenobarbital 60-mg Capsules
Allen Loyd V Jr
Jan/Feb 2014
Pg. 66

Potassium Chloride 2-mEq/mL Injection
Allen Loyd V Jr
Jan/Feb 2014
Pg. 67

Procainamide Hydrochloride 100-mg/mL Injection
Allen Loyd V Jr
Jan/Feb 2014
Pg. 68

Vasopressin 20-units/mL Injection
Allen Loyd V Jr
Jan/Feb 2014
Pg. 69

PreScription: Two Milestones for the International Journal of Pharmaceutical Compounding
Allen Loyd V Jr
Nov/Dec 2013
Pg. 444

Physicians, Pharmacists, and the Importance of Quality Pharmacy Compounding
Allen Loyd V Jr
Nov/Dec 2013
Pg. 477-479

Basics of Compounding: Basics of Compounding with Balsams
Allen Loyd V Jr
Nov/Dec 2013
Pg. 490-495

Benztropine Mesylate 1-mg/mL Injection
Allen Loyd V Jr
Nov/Dec 2013
Pg. 498

Cefazolin 250-mg/mL Injection
Allen Loyd V Jr
Nov/Dec 2013
Pg. 499

Ciprofloxacin 250-mg Capsules
Allen Loyd V Jr
Nov/Dec 2013
Pg. 500

Cortisone Acetate 25-mg Capsules
Allen Loyd V Jr
Nov/Dec 2013
Pg. 501

Cyclopentolate Hydrochloride 0.2% and Phenylephrine Hydrochloride 1% Ophthalmic Solution
Allen Loyd V Jr
Nov/Dec 2013
Pg. 502

Dihydroergotamine Mesylate 1-mg/mL Injection
Allen Loyd V Jr
Nov/Dec 2013
Pg. 503

Hydrocortisone 50-mg/mL Injection (as the Sodium Succinate)
Allen Loyd V Jr
Nov/Dec 2013
Pg. 504

Levothyroxine Sodium 100-mcg Capsules
Allen Loyd V Jr
Nov/Dec 2013
Pg. 505

Metyrosine 250-mg Capsules
Allen Loyd V Jr
Nov/Dec 2013
Pg. 506

Phenytoin Sodium 50-mg/mL Injection
Allen Loyd V Jr
Nov/Dec 2013
Pg. 507

PostScription: Augmented Reality for Readers and Authors
Allen Loyd V Jr
Nov/Dec 2013
Pg. 526-527

PreScription: GMPs vs. GCPs: Manufacturing and Compounding Definitions
Allen Loyd V Jr
Sep/Oct 2013
Pg. 356

Basics of Compounding: Basics of Compounding with Tars
Allen Loyd V Jr
Sep/Oct 2013
Pg. 400-410

Acyclovir 50-mg/mL Injection
Allen Loyd V Jr
Sep/Oct 2013
Pg. 414

Aminocaproic Acid 250-mg/mL Injection
Allen Loyd V Jr
Sep/Oct 2013
Pg. 415

Clindamycin 150-mg/mL Injection
Allen Loyd V Jr
Sep/Oct 2013
Pg. 416

Fluorouracil 50-mg/mL Injection
Allen Loyd V Jr
Sep/Oct 2013
Pg. 417

Hydroxyzine Hydrochloride 25-mg/mL Injection
Allen Loyd V Jr
Sep/Oct 2013
Pg. 418

Indomethacin 1-mg/mL Injection
Allen Loyd V Jr
Sep/Oct 2013
Pg. 419

Mesna 100-mg/mL Injection
Allen Loyd V Jr
Sep/Oct 2013
Pg. 420

Methotrexate 25-mg/mL Injection
Allen Loyd V Jr
Sep/Oct 2013
Pg. 421

Phenylephrine Hydrochloride 10-mg/mL Injection
Allen Loyd V Jr
Sep/Oct 2013
Pg. 422

Terbutaline Sulfate 1-mg/mL Injection
Allen Loyd V Jr
Sep/Oct 2013
Pg. 423

PostScription: GMPs vs. GCPs: United States Pharmacopeia General Chapters
Allen Loyd V Jr
Sep/Oct 2013
Pg. 439

Prescription: International Journal of Pharmaceutical Compounding and MEDLINE Update
Allen Loyd V Jr
Jul/Aug 2013
Pg. 268

Basics of Compounding: Foam Dosage Forms
Allen Loyd V Jr
Jul/Aug 2013
Pg. 312-322

Acyclovir 20-mg/mL Oral Suspension
Allen Loyd V Jr
Jul/Aug 2013
Pg. 326

Acyclovir 200-mg Capsules
Allen Loyd V Jr
Jul/Aug 2013
Pg. 327

Allopurinol Sodium 4-mg/mL Injection
Allen Loyd V Jr
Jul/Aug 2013
Pg. 328

Amikacin Sulfate 250-mg/mL Injection
Allen Loyd V Jr
Jul/Aug 2013
Pg. 329

Dacarbazine 200-mg/mL Injection
Allen Loyd V Jr
Jul/Aug 2013
Pg. 330

Ketamine 50-mg/mL Injection
Allen Loyd V Jr
Jul/Aug 2013
Pg. 331

Methohexital Sodium 500-mg/mL Injection
Allen Loyd V Jr
Jul/Aug 2013
Pg. 332

Metoprolol Tartrate 1-mg/mL Injection
Allen Loyd V Jr
Jul/Aug 2013
Pg. 333

Rifampin 300-mg and Isoniazid 150-mg Capsules
Allen Loyd V Jr
Jul/Aug 2013
Pg. 334

Succinylcholine Chloride 50-mg/mL Injection
Allen Loyd V Jr
Jul/Aug 2013
Pg. 335

PostScription: Traditional vs Nontraditional Pharmacy
Allen Loyd V Jr
Jul/Aug 2013
Pg. 351

PreScription: Compounding for Drug Shortages
Allen Loyd V Jr
May/Jun 2013
Pg. 180

Quality Control Analytical Methods: A Summarized Discussion of Current Good Manufacturing Practice Regulations
Allen Loyd V Jr
May/Jun 2013
Pg. 210-219

Basics of Compounding: Potency and Stability Testing
Allen Loyd V Jr
May/Jun 2013
Pg. 220-224

Buffered Aspirin Capsules
Allen Loyd V Jr
May/Jun 2013
Pg. 228

Calcium Acetate 667-mg Capsules
Allen Loyd V Jr
May/Jun 2013
Pg. 229

Estradiol 0.5-mg, 1-mg, or 2-mg Capsules
Allen Loyd V Jr
May/Jun 2013
Pg. 230

Ethambutol 400-mg Capsules
Allen Loyd V Jr
May/Jun 2013
Pg. 231

Isoniazid 300-mg Capsules
Allen Loyd V Jr
May/Jun 2013
Pg. 232

Labetalol 50-mg Capsules
Allen Loyd V Jr
May/Jun 2013
Pg. 233

Mercaptopurine 75-mg Capsules
Allen Loyd V Jr
May/Jun 2013
Pg. 234

Naltrexone Hydrochloride 50-mg Capsules
Allen Loyd V Jr
May/Jun 2013
Pg. 235

Prednisone 10-mg Capsules
Allen Loyd V Jr
May/Jun 2013
Pg. 236

Reserpine 0.5-mg Capsules
Allen Loyd V Jr
May/Jun 2013
Pg. 237

PreScription: Pharmacy Committees
Allen Loyd V Jr
Mar/Apr 2013
Pg. 92

Basics of Compounding: Repackaging, Part 2
Allen Loyd V Jr
Mar/Apr 2013
Pg. 136-140

Adenosine 3-mg/mL Injection
Allen Loyd V Jr
Mar/Apr 2013
Pg. 144

Alcohol Dehydrated Injection
Allen Loyd V Jr
Mar/Apr 2013
Pg. 145

Betahistine 16-mg Capsules
Allen Loyd V Jr
Mar/Apr 2013
Pg. 146

Ciprofloxacin 10-mg/mL Intravenous Injection Concentrate
Allen Loyd V Jr
Mar/Apr 2013
Pg. 147

Cyanocobalamin 1000-mcg/mL Injection
Allen Loyd V Jr
Mar/Apr 2013
Pg. 148

Dexrazoxane 1-mg/mL Injection
Allen Loyd V Jr
Mar/Apr 2013
Pg. 149

Meropenem 50-mg/mL Injection
Allen Loyd V Jr
Mar/Apr 2013
Pg. 150

Paclitaxel 6-mg/mL Injection
Allen Loyd V Jr
Mar/Apr 2013
Pg. 151

Thiotepa 15-mg/mL Injection
Allen Loyd V Jr
Mar/Apr 2013
Pg. 152

Verapamil Hydrochloride 2.5-mg/mL Injection
Allen Loyd V Jr
Mar/Apr 2013
Pg. 153

PreScription: How Many Pharmacies Compound and What Do They Compound?
Allen Loyd V Jr
Jan/Feb 2013
Pg. 4

Adrenal Fatigue
Allen Loyd V Jr
Jan/Feb 2013
Pg. 39-44

Quality Control: Analytical Methods: Calibration of Equipment and Calibration Curves
Allen Loyd V Jr
Jan/Feb 2013
Pg. 50-53

Basics of Compounding: Repackaging, Part 1
Allen Loyd V Jr
Jan/Feb 2013
Pg. 54-60

Desmopressin 4-mcg/mL Injection
Allen Loyd V Jr
Jan/Feb 2013
Pg. 64

Dobutamine 10-mg/mL Injection
Allen Loyd V Jr
Jan/Feb 2013
Pg. 65

Granisetron 1-mg/mL Injection
Allen Loyd V Jr
Jan/Feb 2013
Pg. 66

Ibuprofen 10-mg/mL Injection
Allen Loyd V Jr
Jan/Feb 2013
Pg. 67

Mepivacaine Hydrochloride 1% Injection
Allen Loyd V Jr
Jan/Feb 2013
Pg. 68

Milrinone 0.2-mg/mL Injection
Allen Loyd V Jr
Jan/Feb 2013
Pg. 69

Neostigmine Methylsulfate 0.5-mg/mL Injection
Allen Loyd V Jr
Jan/Feb 2013
Pg. 70

Nicardipine Hydrochloride Injection
Allen Loyd V Jr
Jan/Feb 2013
Pg. 71

Octreotide 50-mcg/mL Injection
Allen Loyd V Jr
Jan/Feb 2013
Pg. 72

Testosterone Cypionate 100-mg/mL Injection
Allen Loyd V Jr
Jan/Feb 2013
Pg. 73

Errata
Allen Loyd V Jr
Jan/Feb 2013
Pg. 86

PostScription: GMPs and GCPs: A Topical Comparison
Allen Loyd V Jr
Jan/Feb 2013
Pg. 87

PreScription: A Degree in Pharmacy: How Valuable!
Allen Loyd V Jr
Nov/Dec 2012
Pg. 444

Colds and Cough
Allen Loyd V Jr
Nov/Dec 2012
Pg. 480-483

Quality Control: Analytical Methods. Certificates of Analysis, Part 1
Allen Loyd V Jr
Nov/Dec 2012
Pg. 486-488

Basics of Compounding: Implementing United States Pharmacopeia Chapter <1163> Quality Assurance in Pharmaceutical Compounding, Part 5: Outsourcing and Responsible Personnel
Allen Loyd V Jr
Nov/Dec 2012
Pg. 490-496

Aminophylline 25-mg/mL Injection
Allen Loyd V Jr
Nov/Dec 2012
Pg. 500

Ammonium Chloride 5-mEq/mL Injection
Allen Loyd V Jr
Nov/Dec 2012
Pg. 501

Azathioprine 10-mg/mL Injection
Allen Loyd V Jr
Nov/Dec 2012
Pg. 502

Copper 0.4-mg/mL Injection
Allen Loyd V Jr
Nov/Dec 2012
Pg. 503

Dipyridamole 5-mg/mL Injection
Allen Loyd V Jr
Nov/Dec 2012
Pg. 504

Dopamine Hydrochloride 80-mg/mL Injection
Allen Loyd V Jr
Nov/Dec 2012
Pg. 505

Ergotamine Tartrate 1-mg and Caffeine 100-mg Capsules
Allen Loyd V Jr
Nov/Dec 2012
Pg. 506

Papaverine Hydrochloride 30-mg/mL Injection
Allen Loyd V Jr
Nov/Dec 2012
Pg. 507

Valproate Sodium 100-mg/mL Injection
Allen Loyd V Jr
Nov/Dec 2012
Pg. 508

Vercuronium Bromide 1-mg/mL Injection
Allen Loyd V Jr
Nov/Dec 2012
Pg. 509

PreScription: What Is Involved in the Making of Remington's?
Allen Loyd V Jr
Sep/Oct 2012
Pg. 356

Remington: The Science and Practice of Pharmacy: From the Past into the Future
Allen Loyd V Jr
Sep/Oct 2012
Pg. 358-362

Metronidazole 5-mg/mL Injection
Allen Loyd V Jr
Sep/Oct 2012
Pg. 425

Basics of Compounding: Implementing United States Pharmacopeia Chapter <1163> Quality Assurance in Pharmaceutical Compounding, Part 4: Cleaning and Packaging
Allen Loyd V Jr
Sep/Oct 2012
Pg. 405-414

Doxapram Hydrochloride 20-mg/mL injection
Allen Loyd V Jr
Sep/Oct 2012
Pg. 418

Enalaprilat 1.25-mg/mL Injection
Allen Loyd V Jr
Sep/Oct 2012
Pg. 419

Esmolol Hydrochloride 10-mg/mL Injection
Allen Loyd V Jr
Sep/Oct 2012
Pg. 420

Fluconazole 2-mg/mL Injection
Allen Loyd V Jr
Sep/Oct 2012
Pg. 421

Haloperidol 50-mg/mL in Oil Injection
Allen Loyd V Jr
Sep/Oct 2012
Pg. 422

Meperidine Hydrochloride 50-mg/mL Injection
Allen Loyd V Jr
Sep/Oct 2012
Pg. 423

Methocarbamol 100-mg/mL Injection
Allen Loyd V Jr
Sep/Oct 2012
Pg. 424

Nalbuphine Hydrochloride 10-mg/mL Injection
Allen Loyd V Jr
Sep/Oct 2012
Pg. 426

Oxymorphone Hydrochloride 1-mg/mL Injection
Allen Loyd V Jr
Sep/Oct 2012
Pg. 427

PostScription: Remington Twenty-Second Edition
Allen Loyd V Jr
Sep/Oct 2012
Pg. 438

PreScription: Lifelong Learning
Allen Loyd V Jr
Jul/Aug 2012
Pg. 268

PreScription: Drug Shortages and Discontinued Drugs
Allen Loyd V Jr
Jul/Aug 2012
Pg. 268

A Concise Discussion of Headache Types, Part 3: Migraine
Williams LaVonn A
, Allen Loyd V Jr
Jul/Aug 2012
Pg. 270-274

Drug Shortages & Discontinued Drugs: The Effects on Patients and Healthcare Providers
Allen Loyd V Jr
, Williams LaVonn A
Jul/Aug 2012
Pg. 294-298

Basics of Compounding: Implementing United States Pharmacopeia Chapter <1163> Quality Assurance in Pharmaceutical Compounding, Part 3: Testing
Allen Loyd V Jr
Jul/Aug 2012
Pg. 322-328

Betamethasone 0.6-mg/5-mL Syrup
Allen Loyd V Jr
Jul/Aug 2012
Pg. 332

Butorphanol Tartrate 2-mg/mL Injection
Allen Loyd V Jr
Jul/Aug 2012
Pg. 333

Diphenhydramine Hydrochloride 50-mg/mL Injection
Allen Loyd V Jr
Jul/Aug 2012
Pg. 334

Etomidate 2-mg/mL Injection
Allen Loyd V Jr
Jul/Aug 2012
Pg. 335

Foscarnet Sodium 24-mg/mL Injection
Allen Loyd V Jr
Jul/Aug 2012
Pg. 336

Ketorolac Tromethamine 15-mg/mL Injection
Allen Loyd V Jr
Jul/Aug 2012
Pg. 337

Methyldopate Hydrochloride 50-mg/mL Injection
Allen Loyd V Jr
Jul/Aug 2012
Pg. 338

Ondansetron Hydrochloride 2-mg/mL Injection
Allen Loyd V Jr
Jul/Aug 2012
Pg. 339

Sufentanil Citrate 50-mcg/mL Injection
Allen Loyd V Jr
Jul/Aug 2012
Pg. 340

Tobramycin 40-mg/mL Injection
Allen Loyd V Jr
Jul/Aug 2012
Pg. 341

PostScription: Drug Shortages and Discontinued Drugs: Their Effects on Healthcare
Allen Loyd V Jr
, Williams LaVonn A
Jul/Aug 2012
Pg. 350-351

PreScription: You're On Your Own
Allen Loyd V Jr
May/Jun 2012
Pg. 180

Treatment and Prevention of Insect Bites: Mosquitoes
Williams LaVonn A
, Allen Loyd V Jr
May/Jun 2012
Pg. 210-218

Basics of Compounding: Implementing United States Pharmacopeia Chapter <1163> Quality Assurance in Pharmaceutical Compounding, Part 2: Documentation and Verification
Allen Loyd V Jr
May/Jun 2012
Pg. 230-234

Acetazolamide 100-mg/mL Injection
Allen Loyd V Jr
May/Jun 2012
Pg. 238

Alfentanil 500-mcg/mL Injection
Allen Loyd V Jr
May/Jun 2012
Pg. 239

Ascorbic Acid 250-mg/mL Injection
Allen Loyd V Jr
May/Jun 2012
Pg. 240

Diltiazem Hydrochloride 5-mg/mL Injection
Allen Loyd V Jr
May/Jun 2012
Pg. 241

Famotidine 10-mg/mL Injection
Allen Loyd V Jr
May/Jun 2012
Pg. 242

Metoclopramide 5-mg/mL Injection
Allen Loyd V Jr
May/Jun 2012
Pg. 243

Naloxone Hydrochloride 1-mg/mL Injection
Allen Loyd V Jr
May/Jun 2012
Pg. 244

Orphenadrine Citrate 30-mg/mL Injection
Allen Loyd V Jr
May/Jun 2012
Pg. 245

Prochlorperazine 5-mg/mL Injection
Allen Loyd V Jr
May/Jun 2012
Pg. 246

Ranitidine 25-mg/mL Injection
Allen Loyd V Jr
May/Jun 2012
Pg. 247

PreScription: Support the Organizations that Support You and Your Practice
Allen Loyd V Jr
Mar/Apr 2012
Pg. 92

Midazolam 5-mg/mL Injection
Allen Loyd V Jr
Mar/Apr 2012
Pg. 162

Promethazine Hydrochloride 50-mg/mL Injection
Allen Loyd V Jr
Mar/Apr 2012
Pg. 163

Basics of Compounding: Implementing United States Pharmacopeia Chapter <1163> Quality Assurance in Pharmaceutical Compounding, Part 1
Allen Loyd V Jr
Mar/Apr 2012
Pg. 146-150

Amiodarone Hydrochloride 50-mg/mL Injection
Allen Loyd V Jr
Mar/Apr 2012
Pg. 154

Bupivacaine Hydrochloride 0.5% with Epinephrine 1:200,000 Injection
Allen Loyd V Jr
Mar/Apr 2012
Pg. 155

Caffeine Citrate 20-mg/mL Injection
Allen Loyd V Jr
Mar/Apr 2012
Pg. 156

Chromium 4-mcg/mL Injection
Allen Loyd V Jr
Mar/Apr 2012
Pg. 157

Furosemide 10-mg/mL Injection
Allen Loyd V Jr
Mar/Apr 2012
Pg. 158

Glycopyrrolate 0.2-mg/mL Injection
Allen Loyd V Jr
Mar/Apr 2012
Pg. 159

Labetalol Hydrochloride 5-mg/mL Injection
Allen Loyd V Jr
Mar/Apr 2012
Pg. 160

Lorazepam 4-mg/mL Injection
Allen Loyd V Jr
Mar/Apr 2012
Pg. 161

Sodium Chloride 14.6% and 23.4% Injections
Allen Loyd V Jr
Jan/Feb 2012
Pg. 77

Sodium Phosphates Injection
Allen Loyd V Jr
Jan/Feb 2012
Pg. 78

Zinc 1-mg/mL and 5-mg/mL Injections
Allen Loyd V Jr
Jan/Feb 2012
Pg. 79

PreScription: Fifteen Years and Counting
Allen Loyd V Jr
Jan/Feb 2012
Pg. 4

Sodium Acetate 2-mEq/mL and 4-mEq/mL Injections
Allen Loyd V Jr
Jan/Feb 2012
Pg. 75

Sodium Bicarbonate 4.2%, 5.0%, 7.5%, and 8.4% Injections
Allen Loyd V Jr
Jan/Feb 2012
Pg. 76

Basics of Compounding: Implementing United States Pharmacopeia Chapter <795> Pharmaceutical Compounding–Nonsterile Preparations, Part 4
Allen Loyd V Jr
Jan/Feb 2012
Pg. 64-68

Calcium Chloride 10% Injection
Allen Loyd V Jr
Jan/Feb 2012
Pg. 70

Calcium Gluconate 10% Injection
Allen Loyd V Jr
Jan/Feb 2012
Pg. 71

Magnesium Sulfate 10% Injection (0.8 mEq/mL)
Allen Loyd V Jr
Jan/Feb 2012
Pg. 72

Potassium Acetate 2-mEq/mL and 4-mEq/mL Injections
Allen Loyd V Jr
Jan/Feb 2012
Pg. 73

Potassium Phosphates Injection
Allen Loyd V Jr
Jan/Feb 2012
Pg. 74

PreScription: Not All Pharmacists Should Compound!
Allen Loyd V Jr
Nov/Dec 2011
Pg. 444

Basics of Compounding: Implementing United States Pharmacopeia Chapter <795> Pharmaceutical Compounding--Nonsterile Preparations, Part 3
Allen Loyd V Jr
Nov/Dec 2011
Pg. 488-496

Cefepime 1% Ophthalmic Solution
Allen Loyd V Jr
Nov/Dec 2011
Pg. 500

Citric Acid 3% Mouthrinse Solution
Allen Loyd V Jr
Nov/Dec 2011
Pg. 501

Dapsone 5% Topical Gel
Allen Loyd V Jr
Nov/Dec 2011
Pg. 502

Lavender Oil 4% in Polyethylene Glycol Ointment
Allen Loyd V Jr
Nov/Dec 2011
Pg. 503

Oxandrolone 2-mg/mL Oral Liquid
Allen Loyd V Jr
Nov/Dec 2011
Pg. 505

Thioguanine 20-mg/mL Oral Suspension
Allen Loyd V Jr
Nov/Dec 2011
Pg. 506

Tobramycin Fortified 13.5-mg/mL Ophthalmic Solution
Allen Loyd V Jr
Nov/Dec 2011
Pg. 507

Vancomycin 31-mg/mL Ophthalmic Solution
Allen Loyd V Jr
Nov/Dec 2011
Pg. 508

Morphine 6-mg/mL, Haloperidol 0.5-mg/mL, and Hyoscine 6-mg/mL Infusion
Allen Loyd V Jr
Nov/Dec 2011
Pg. 504

Vancomycin 2% in Silver Sulfadiazine Cream
Allen Loyd V Jr
Nov/Dec 2011
Pg. 509

PreScription: Third-party Inequities and Discrimination
Allen Loyd V Jr
Sep/Oct 2011
Pg. 356

Basics of Compounding: Implementing United States Pharmacopeia Chapter <795> Pharmaceutical Compounding--Nonsterile Preparations, Part 2
Allen Loyd V Jr
Sep/Oct 2011
Pg. 408-414

Carvedilol 0.625-mg/mL Oral Liquid
Allen Loyd V Jr
Sep/Oct 2011
Pg. 418

Granisetron Hydrochloride 0.2-mg/mL Oral Suspension
Allen Loyd V Jr
Sep/Oct 2011
Pg. 419

Lorazepam 1-mg/mL Oral Suspension
Allen Loyd V Jr
Sep/Oct 2011
Pg. 420

Metoprolol Tartrate 1.25-mg/mL Oral Liquid
Allen Loyd V Jr
Sep/Oct 2011
Pg. 421

Nifedipine 1-mg/500-mg Oral Powder
Allen Loyd V Jr
Sep/Oct 2011
Pg. 422

Nifedipine 10-mg/mL Oral Suspension
Allen Loyd V Jr
Sep/Oct 2011
Pg. 423

Rebamipide Rectal Enema Suspension
Allen Loyd V Jr
Sep/Oct 2011
Pg. 424

Sotalol 5-mg/mL Oral Suspension
Allen Loyd V Jr
Sep/Oct 2011
Pg. 425

Sulfadiazine 100-mg/mL Oral Suspension
Allen Loyd V Jr
Sep/Oct 2011
Pg. 426

Ursodiol 50-mg/mL Oral Suspension
Allen Loyd V Jr
Sep/Oct 2011
Pg. 427

Transdermals: The Skin as Part of a Drug Delivery System
Allen Loyd V Jr
Jul/Aug 2011
Pg. 308-315

Basics of Compounding: Implementing United States Pharmacopeia Chapter <795> Pharmaceutical Compounding--Nonsterile Preparations, Part 1
Allen Loyd V Jr
Jul/Aug 2011
Pg. 328-331

Anesthetic Nasal Ointment
Allen Loyd V Jr
Jul/Aug 2011
Pg. 334

Citric Acid, Potassium Citrate, and Sodium Citrate Solution
Allen Loyd V Jr
Jul/Aug 2011
Pg. 335

Cromolyn Sodium 50-mg/mL Oral Suspension
Allen Loyd V Jr
Jul/Aug 2011
Pg. 336

Glycopyrrolate 0.5-mg/mL Oral Suspension
Allen Loyd V Jr
Jul/Aug 2011
Pg. 337

Hydrocortisone 100-mg/60-mL Retention Enema
Allen Loyd V Jr
Jul/Aug 2011
Pg. 338

Magnesium Sulfate Paste
Allen Loyd V Jr
Jul/Aug 2011
Pg. 339

Quetiapine Fumarate 40-mg/mL Nonaqueous Oral Suspension
Allen Loyd V Jr
Jul/Aug 2011
Pg. 342

Riboflavin 5-mg/mL Oral Suspension
Allen Loyd V Jr
Jul/Aug 2011
Pg. 343

PreScription: The Science and Technology of Hospital Pharmacy Newsletter
Allen Loyd V Jr
Jul/Aug 2011
Pg. 268

Methylprednisolone 4-mg/mL Oral Suspension
Allen Loyd V Jr
Jul/Aug 2011
Pg. 340

Oxandrolone 1-mg/mL Oral Suspension
Allen Loyd V Jr
Jul/Aug 2011
Pg. 341

PostScription: Announcement
Allen Loyd V Jr
May/Jun 2011
Pg. 262

PreScription: Greed Does Not Pay! Makena, Lucentis, and Others
Allen Loyd V Jr
May/Jun 2011
Pg. 180

Basics of Compounding: Basics of Compounding with Complex Organic Molecules
Allen Loyd V Jr
May/Jun 2011
Pg. 234-238

Amitriptyline 4%, Dextromethorphan Hydrobromide 20%, and Tramadol Hydrochloride 5% in Pluronic Lecithin Organogel Gel
Allen Loyd V Jr
May/Jun 2011
Pg. 242

Diclofenac Sodium 1% Topical Gel
Allen Loyd V Jr
May/Jun 2011
Pg. 243

Ibuprofen 5% Topical Cream
Allen Loyd V Jr
May/Jun 2011
Pg. 244

Melatonin 1-mg/mL Oral Suspension
Allen Loyd V Jr
May/Jun 2011
Pg. 246

Sport Body Cooler
Allen Loyd V Jr
May/Jun 2011
Pg. 247

Tannic Acid 5% Alcohol Gel
Allen Loyd V Jr
May/Jun 2011
Pg. 248

Triamcinolone 0.1% Lotion
Allen Loyd V Jr
May/Jun 2011
Pg. 249

Ketoprofen 10%, Ibuprofen 10%, Cyclobenzaprine Hydrochloride 2%, and Piroxicam 2% in Pluronic Lecithin Organogel Gel
Allen Loyd V Jr
May/Jun 2011
Pg. 245

Triclosan 2% Topical Cream
Allen Loyd V Jr
May/Jun 2011
Pg. 250

Wound Cleaner Solution
Allen Loyd V Jr
May/Jun 2011
Pg. 251

PreScription: Discontinued Drugs and Drug Shortages
Allen Loyd V Jr
Mar/Apr 2011
Pg. 92

Basics of Compounding: Basics of Compounding with Inorganic Salts
Allen Loyd V Jr
Mar/Apr 2011
Pg. 146-153

Acetylcysteine 1% or 10% Oral Solution
Allen Loyd V Jr
Mar/Apr 2011
Pg. 156

Amitriptyline Hydrochloride 2%, Carbamazepine 2%, Gabapentin 10%, and Ketoprofen 2% Transdermal Gel
Allen Loyd V Jr
Mar/Apr 2011
Pg. 157

Clopidogrel 5-mg/mL Oral Suspension
Allen Loyd V Jr
Mar/Apr 2011
Pg. 158

Dextromethorphan Hydrobromide 15-mg Oral Film Strip
Allen Loyd V Jr
Mar/Apr 2011
Pg. 159

Hank's Balanced Salt Solution (Stock Solution)
Allen Loyd V Jr
Mar/Apr 2011
Pg. 160

Levamisole 25-mg/mL Oral Solution
Allen Loyd V Jr
Mar/Apr 2011
Pg. 161

Mandl's Paint
Allen Loyd V Jr
Mar/Apr 2011
Pg. 162

Massage Rub, Oil Free
Allen Loyd V Jr
Mar/Apr 2011
Pg. 163

Oral Film Strip Vehicle
Allen Loyd V Jr
Mar/Apr 2011
Pg. 164

Tea Tree Oil Acne Gel
Allen Loyd V Jr
Mar/Apr 2011
Pg. 165

Erratum: Stability of Venlafaxine Immediate-Release Suspensions
Allen Loyd V Jr
Mar/Apr 2011
Pg. 175

PreScription: The Resources of the International Journal of Pharmaceutical Compounding, Inc.; Sterile Compounding Meets Needs for Patients, Professionals
Allen Loyd V Jr
, Menighan Thomas E
Jan/Feb 2011
Pg. 4

Basics of Compounding: Basics of Compounding with Potency Designated Ingredients
Allen Loyd V Jr
Jan/Feb 2011
Pg. 56-61

Diclofenac Sodium 10-mg/mL Oral Suspension
Allen Loyd V Jr
Jan/Feb 2011
Pg. 64

Hydrocortisone Acetate 1% Gel, Alcohol-Free
Allen Loyd V Jr
Jan/Feb 2011
Pg. 65

Ibuprofen 5% Gel
Allen Loyd V Jr
Jan/Feb 2011
Pg. 66

Mandelic Acid 5% Cream
Allen Loyd V Jr
Jan/Feb 2011
Pg. 67

Methotrexate 30-mg/g Topical Gel
Allen Loyd V Jr
Jan/Feb 2011
Pg. 68

Piroxicam 1% Gel
Allen Loyd V Jr
Jan/Feb 2011
Pg. 69

Pramoxine 1% Cream
Allen Loyd V Jr
Jan/Feb 2011
Pg. 70

Sodium Nitroprusside and Sodium Thiosulfate Intravenous Admixture
Allen Loyd V Jr
Jan/Feb 2011
Pg. 71

Terbenafine Hydrochloride Bilayer Nail Lacquer
Allen Loyd V Jr
Jan/Feb 2011
Pg. 72

Vancomycin Hydrochloride 25-mg/mL Solution
Allen Loyd V Jr
Jan/Feb 2011
Pg. 73

Basics of Compounding: Basics of Compounding with Aliquots, Dilutions, and Concentrates
Allen Loyd V Jr
Nov/Dec 2010
Pg. 508-510

Amitriptyline Hydrochloride 2%, Baclofen 5%, Ketamine Hydrochloride 5%, Ketoprofen 10% in Pluronic Lecithin Organogel
Allen Loyd V Jr
Nov/Dec 2010
Pg. 512

Baclofen 5%, Capcaicin 0.075%, Ketoprofen 10%, and Tetracaine 2% in Pluronic Lecithin Organogel
Allen Loyd V Jr
Nov/Dec 2010
Pg. 513

Baclofen 5%, Gabapentin 5%, Ketoprofen 10%, and Lidocaine 5% in Pluronic Lecithin Organogel
Allen Loyd V Jr
Nov/Dec 2010
Pg. 514

Capsaicin 0.05% Clear Medication Stick
Allen Loyd V Jr
Nov/Dec 2010
Pg. 517

Glutathione 25% in Pluronic Lecithin Organogel
Allen Loyd V Jr
Nov/Dec 2010
Pg. 518

Gramicidin 13% Ophthalmic Solution
Allen Loyd V Jr
Nov/Dec 2010
Pg. 519

Ketoprofen 2% Oral Gel
Allen Loyd V Jr
Nov/Dec 2010
Pg. 521

PreScription: Compounding with Manufactured Products
Allen Loyd V Jr
Nov/Dec 2010
Pg. 448

Bromazepam 2.5-mg/mL Drops
Allen Loyd V Jr
Nov/Dec 2010
Pg. 515

Bromhexine Hydrochloride 0.8-mg/mL Syrup
Allen Loyd V Jr
Nov/Dec 2010
Pg. 516

Ketoprofen 5% and Lidocaine Hydrochloride 0.5% Topical Gel
Allen Loyd V Jr
Nov/Dec 2010
Pg. 520

PreScription: Revised Format
Allen Loyd V Jr
Sep/Oct 2010
Pg. 358

Alpha-Bisabolol Mouthwash
Allen Loyd V Jr
Sep/Oct 2010
Pg. 420

Icy Blue Camphorated Gel
Allen Loyd V Jr
Sep/Oct 2010
Pg. 422

Carvedilol 1-mg/mL Oral Suspension
Allen Loyd V Jr
Sep/Oct 2010
Pg. 423

Basics of Compounding: Basics of Compounding with Esters
Allen Loyd V Jr
Sep/Oct 2010
Pg. 416-418

Buspirone 2.5-mg/mL Oral Suspension
Allen Loyd V Jr
Sep/Oct 2010
Pg. 424

Three Fortified Ophthalmic Solutions: Amikacin 5% Ophthalmic Solution; Ceftazidime 5% Ophthalmic Solution; Vancomycin 5% Ophthalmic Solution
Allen Loyd V Jr
Sep/Oct 2010
Pg. 421

Triclosan 0.28% Mouthwash
Allen Loyd V Jr
Sep/Oct 2010
Pg. 425

Rufinamide 40-mg/mL Oral Suspension
Allen Loyd V Jr
Sep/Oct 2010
Pg. 426

Haloperidol 0.416-mg/mL, Hyoscine 4.9-mg/mL, and Tramadol 16.67-mg/mL in 0.9% Sodium Chloride Injection
Allen Loyd V Jr
Sep/Oct 2010
Pg. 427

Panitumumab 2.5-mg/mL in 0.9% Sodium Chloride Injection
Allen Loyd V Jr
Sep/Oct 2010
Pg. 428

Polidocanol 0.5% Wound Spray
Allen Loyd V Jr
Sep/Oct 2010
Pg. 429

PreScription: Beginning of a New United States Pharmacopeial Convention, Inc., Cycle
Allen Loyd V Jr
Jul/Aug 2010
Pg. 268

Hygrometers and Thermohygrometers: Environmental Monitoring Ensures the Potency and Stability of Compounding Agents
Allen Loyd V Jr
, McKenzie Robert, Ainsworth Ron, Kastango Eric S, Kaestner Rick, Rebelo Andre, Burnside Paul, Schultz Gerald
Jul/Aug 2010
Pg. 284-300

Acyclovir with Benzocaine Lip Balm
Allen Loyd V Jr
Jul/Aug 2010
Pg. 332

Acyclovir 5% Lip Balm with Dioxybenzone and Oxybenzone
Allen Loyd V Jr
Jul/Aug 2010
Pg. 333

Amitriptyline Hydrochloride Suppositories
Allen Loyd V Jr
Jul/Aug 2010
Pg. 334

Basics of Compounding: Basics of Compounding with Organic Salts
Allen Loyd V Jr
Jul/Aug 2010
Pg. 322-326

Basics of Compounding: Considerations for Implementing USP Chapter <797> Pharmacy Compounding -- Sterile Preparations, Part 20: Patient or Caregiver Training, Patient Monitoring and Adverse Events Reporting, and Quality-Assurance Program
Okeke Claudia C
, Allen Loyd V Jr
Jul/Aug 2010
Pg. 328-331

Ampicillin 250-mg Suppository
Allen Loyd V Jr
Jul/Aug 2010
Pg. 335

Antazoline Phosphate and Xylometazoline Hydrochloride Ophthalmic Drops
Allen Loyd V Jr
Jul/Aug 2010
Pg. 336

Buprenorphine Hydrochloride Injection
Allen Loyd V Jr
Jul/Aug 2010
Pg. 337

Chloroprocaine Hydrochloride Injection
Allen Loyd V Jr
Jul/Aug 2010
Pg. 338

Cyanocobalamin, Choline, and Niacinamide Injection
Allen Loyd V Jr
Jul/Aug 2010
Pg. 339

Fenoldopam Mesylate Injection
Allen Loyd V Jr
Jul/Aug 2010
Pg. 340

Flurbiprofen 5% Bioadhesive Gel for Gingivitis
Allen Loyd V Jr
Jul/Aug 2010
Pg. 341

PreScription: Quality Improvement in Pharmaceutical Compounding
Allen Loyd V Jr
May/Jun 2010
Pg. 180

Bacitracin 10,000-Units/mL Ophthalmic Solution
Allen Loyd V Jr
May/Jun 2010
Pg. 240

Carprofen 2.5-mg/mL Oral Suspension, Veterinary
Allen Loyd V Jr
May/Jun 2010
Pg. 241

Celecoxib 10-mg/mL Oral Suspension
Allen Loyd V Jr
May/Jun 2010
Pg. 242

Basics of Compounding: Compounding with Hydrates and Solvates
Allen Loyd V Jr
May/Jun 2010
Pg. 222-229

Basics of Compounding: Considerations for Implementing USP Chapter <797> -- Sterile Preparations, Part 19: Storage and Beyond-Use Dating, Maintaining Sterility, Purity, and Stability of Dispensed and Distributed Compounded Sterile Preparations
Okeke Claudia C
, Allen Loyd V Jr
May/Jun 2010
Pg. 232-238

Clozapine 20-mg/mL Oral Suspension
Allen Loyd V Jr
May/Jun 2010
Pg. 243

Cohen's Rectal Ointment
Allen Loyd V Jr
May/Jun 2010
Pg. 244

Cyclophosphamide 10-mg/mL Oral Suspension
Allen Loyd V Jr
May/Jun 2010
Pg. 245

Lansoprazole 3-mg/mL Oral Suspension
Allen Loyd V Jr
May/Jun 2010
Pg. 246

Rifaximin 20-mg/mL Oral Suspension
Allen Loyd V Jr
May/Jun 2010
Pg. 247

Sunitinib 10-mg/mL Oral Suspension
Allen Loyd V Jr
May/Jun 2010
Pg. 248

Voriconazole 40-mg/mL Oral Suspension, Veterinary
Allen Loyd V Jr
May/Jun 2010
Pg. 249

PreScription: The Ages of Man
Allen Loyd V Jr
Mar/Apr 2010
Pg. 92

Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 18: Verification of Automated Compounding Devices for Parenteral Nutrition Compounding and Finished Preparation Release Checks and Tests
Allen Loyd V Jr
, Okeke Claudia C
Mar/Apr 2010
Pg. 142-149

Acyclovir 5% in Oral Adhesive Paste
Allen Loyd V Jr
Mar/Apr 2010
Pg. 150

Acyclovir 200-mg/5-mL Oral Suspension (From the Injection)
Allen Loyd V Jr
Mar/Apr 2010
Pg. 151

Ciclopirox 10% in Isopropyl Alcohol Nail Solution
Allen Loyd V Jr
Mar/Apr 2010
Pg. 152

Clotrimazole 1% Oral Adhesive Paste
Allen Loyd V Jr
Mar/Apr 2010
Pg. 153

Cyclosporin 10-mg/g in Oral Adhesive Paste
Allen Loyd V Jr
Mar/Apr 2010
Pg. 154

Dexpanthenol 5% Gel-Cream
Allen Loyd V Jr
Mar/Apr 2010
Pg. 155

Lamotrigine 25-mg/mL Injection
Allen Loyd V Jr
Mar/Apr 2010
Pg. 156

Metolazone 10-mg/mL Injection
Allen Loyd V Jr
Mar/Apr 2010
Pg. 157

Plasticized Hydrocarbon Gel
Allen Loyd V Jr
Mar/Apr 2010
Pg. 158

Oral Adhesive Paste
Allen Loyd V Jr
Mar/Apr 2010
Pg. 159

PostScription: Is Being Involved in the Pharmacy Student Preceptor Program Worth the Effort?
Allen Loyd V Jr
, Burger Mark
Mar/Apr 2010
Pg. 174-175

Ketoprofen 100-mg/5-mL Mouth Rinse
Allen Loyd V Jr
Jan/Feb 2010
Pg. 68

Metronidazole in Normal Saline Enema
Allen Loyd V Jr
Jan/Feb 2010
Pg. 69

Ophthalmic Toning-Lubricating Drops
Allen Loyd V Jr
Jan/Feb 2010
Pg. 70

Solprotex 2.5% Lotion
Allen Loyd V Jr
Jan/Feb 2010
Pg. 71

Testosterone 1% in Alcoholic Gel
Allen Loyd V Jr
Jan/Feb 2010
Pg. 72

Tetracaine 4% and Menthol 5% Topical Gel
Allen Loyd V Jr
Jan/Feb 2010
Pg. 73

Trigger Point Gel
Allen Loyd V Jr
Jan/Feb 2010
Pg. 75

PreScription: APhA and IJPC Working Together
Allen Loyd V Jr
Jan/Feb 2010
Pg. 4

Hand Sanitizer Gel
Allen Loyd V Jr
Jan/Feb 2010
Pg. 66

Hydrocarbon-Free Lotion
Allen Loyd V Jr
Jan/Feb 2010
Pg. 67

Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmacy Compounding Sterile Preparations, Part 17: Elements of Quality Control
Okeke Claudia C
, Allen Loyd V Jr
Jan/Feb 2010
Pg. 60-64

Tobramycin Sulfate 0.3% and Diclofenac Sodium 0.1% Ophthalmic Solution
Allen Loyd V Jr
Jan/Feb 2010
Pg. 74

Postscription: 2010 A New Year, New Commitments, and New Challenges
Allen Loyd V Jr
Jan/Feb 2010
Pg. 86

PreScription: Geriatric Compounding: An Opportunity for Pharmacists
Allen Loyd V Jr
Nov/Dec 2009
Pg. 492

Cidofovir 0.2-mg/mL Intravitreous Injection
Allen Loyd V Jr
Nov/Dec 2009
Pg. 554

Fluconazole 2% Topical Microemulsion
Allen Loyd V Jr
Nov/Dec 2009
Pg. 555

Gentian Violet Vaginal Suppositories
Allen Loyd V Jr
Nov/Dec 2009
Pg. 556

Ichthammol 10% Otic Solution
Allen Loyd V Jr
Nov/Dec 2009
Pg. 557

Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 16: Suggested Standard Operating Procedures
Okeke Claudia C
, Allen Loyd V Jr
Nov/Dec 2009
Pg. 546-553

Lubow's Solution
Allen Loyd V Jr
Nov/Dec 2009
Pg. 558

Miconazole 1% Ophthalmic Solution, Veterinary
Allen Loyd V Jr
Nov/Dec 2009
Pg. 559

Topiramate 6-mg/mL Oral Suspension
Allen Loyd V Jr
Nov/Dec 2009
Pg. 560

Twevan Cream
Allen Loyd V Jr
Nov/Dec 2009
Pg. 561

Voriconazole 2% Ophthalmic Solution
Allen Loyd V Jr
Nov/Dec 2009
Pg. 562

Wound Gel
Allen Loyd V Jr
Nov/Dec 2009
Pg. 563

PreScription: Veterinary Pharmacy
Allen Loyd V Jr
Sep/Oct 2009
Pg. 356

Aceclofenac 1.5% Pluronic Lecithin Organogel
Allen Loyd V Jr
Sep/Oct 2009
Pg. 428

Amlodipine Besylate 1 mg/mL Veterinary Suspension
Allen Loyd V Jr
Sep/Oct 2009
Pg. 429

Cooling Ointment
Allen Loyd V Jr
Sep/Oct 2009
Pg. 430

Emanuel Butt Paste
Allen Loyd V Jr
Sep/Oct 2009
Pg. 431

Ferric Pyrophosphate 50-mg/mL Solution for Iontophoresis
Allen Loyd V Jr
Sep/Oct 2009
Pg. 432

Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chater <797> Pharmaceutical Compounding--Sterile Preparations, Part 15: Personnel Training, Cleansing, and Garbing
Okeke Claudia C
, Allen Loyd V Jr
Sep/Oct 2009
Pg. 420-426

Lidocaine 10% Oral Pluronic Lecithin Organogel
Allen Loyd V Jr
Sep/Oct 2009
Pg. 433

Mechlorethamine Hydrochloride 0.02% Topical
Allen Loyd V Jr
Sep/Oct 2009
Pg. 434

Myristyl Nicotinate 5% Topical Gel
Allen Loyd V Jr
Sep/Oct 2009
Pg. 435

Nitroglycerin 4-mg Suppository
Allen Loyd V Jr
Sep/Oct 2009
Pg. 436

Zonisamide 10-mg/mL Oral Suspension
Allen Loyd V Jr
Sep/Oct 2009
Pg. 437

Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 14: Environmental Quality and Control (Continued)
Okeke Claudia C
, Allen Loyd V Jr
Jul/Aug 2009
Pg. 322-329

Instant Voice
Allen Loyd V Jr
Jul/Aug 2009
Pg. 336

Moxifloxacin 20-mg/mL Oral Liquid
Allen Loyd V Jr
Jul/Aug 2009
Pg. 337

Mupirocin 1% (20-mg) Vaginal Suppository
Allen Loyd V Jr
Jul/Aug 2009
Pg. 338

Riley Butt Cream
Allen Loyd V Jr
Jul/Aug 2009
Pg. 339

Selegiline Hydrochloride 1-mg/0.05-mL Oral Suspension in Oil
Allen Loyd V Jr
Jul/Aug 2009
Pg. 340

Trolamine Oleate Otic Solution
Allen Loyd V Jr
Jul/Aug 2009
Pg. 341

PreScription: Trust
Allen Loyd V Jr
Jul/Aug 2009
Pg. 268

Alcohol-based Carbomer Gel
Allen Loyd V Jr
Jul/Aug 2009
Pg. 332

Benzoyl Peroxide 10% Gel
Allen Loyd V Jr
Jul/Aug 2009
Pg. 333

Clindamycin 100-mg Vaginal Suppositories
Allen Loyd V Jr
Jul/Aug 2009
Pg. 334

Dexamethasone and Furosemide Injection
Allen Loyd V Jr
Jul/Aug 2009
Pg. 335

PreScription: A Good Name: Pharmacy
Allen Loyd V Jr
May/Jun 2009
Pg. 180

Analgesic Compound Lotion, Clear
Allen Loyd V Jr
May/Jun 2009
Pg. 240

Hydromorphone Hydrochloride 10-mg/mL Oral Drops
Allen Loyd V Jr
May/Jun 2009
Pg. 241

Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 13: Environmental Quality and Control
Allen Loyd V Jr
, Okeke Claudia C
May/Jun 2009
Pg. 234-238

Lidocaine 2% Popsicle
Allen Loyd V Jr
May/Jun 2009
Pg. 242

Morphine Sulfate 10-mg/mL Oral Solution
Allen Loyd V Jr
May/Jun 2009
Pg. 243

Morphine Sulfate 50 mg/mL in Pluronic Lecithin Organogel
Allen Loyd V Jr
May/Jun 2009
Pg. 244

Oxycodone Hydrochloride 10 mg/mL in Pluronic Lecithin Organogel
Allen Loyd V Jr
May/Jun 2009
Pg. 245

Oxycodone Hydrochloride 10-mg and Dextromethorphan 20-mg capsules
Allen Loyd V Jr
May/Jun 2009
Pg. 246

Oxycodone Hydrochloride 20-mg Suppository
Allen Loyd V Jr
May/Jun 2009
Pg. 247

Promethazine 20-mg and Acetaminophen 325-mg Suppositories
Allen Loyd V Jr
May/Jun 2009
Pg. 248

Propoxyphene Hydrochloride 100-mg with Dextromethorphan Hydrobromide 30-mg Capsules
Allen Loyd V Jr
May/Jun 2009
Pg. 249

PreScription: Electronic Prescribing
Allen Loyd V Jr
Mar/Apr 2009
Pg. 92

Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 12: Sterilization Methods
Allen Loyd V Jr
, Okeke Claudia C
Mar/Apr 2009
Pg. 146-150

Acidified Sodium Hypochlorite for Antisepsis and Disinfection
Allen Loyd V Jr
Mar/Apr 2009
Pg. 152

Aprepitant 20-mg/mL Oral Liquid
Allen Loyd V Jr
Mar/Apr 2009
Pg. 153

Chloroquine Phosphate 64.5-mg/mL Injection
Allen Loyd V Jr
Mar/Apr 2009
Pg. 154

Doxorubicin Hydrochloride 1-mg/mL in Sodium Chloride Solution Intravesical Instillation
Allen Loyd V Jr
Mar/Apr 2009
Pg. 155

Return to Top